: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

As of October 2023, Amedeo had
12,263 active subscribers

Head and Neck Cancer

Free Subscription

Articles published in Oral Oncol
Retrieve available abstracts of 834 articles:
HTML format

Single Articles

December 2023

CUNHA JLS
Comment on "Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers".
Oral Oncol. 2023;147:106628.
PubMed

WILLIAMSON A, Moen CM, Slim MAM, Warner L, et al
Transoral robotic surgery without adjuvant therapy: A systematic review and meta-analysis of the association between surgical margins and local recurrence.
Oral Oncol. 2023;147:106610.
PubMed Abstract available

SILVA CUNHA JL
Comment on "Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer".
Oral Oncol. 2023;147:106626.
PubMed

TIRELLI G, Boscolo-Rizzo P
Palatoglossus muscle involvement in oropharynx Carcinoma: A pitfall in the T4 category definition of the 8th edition of the TNM staging system?
Oral Oncol. 2023;147:106627.
PubMed

FARLOW JL, McCrary HC, Sipos JA, Phay JE, et al
Neoadjuvant dabrafenib and trametinib for functional organ preservation in recurrent BRAF V600E-mutated papillary thyroid cancer.
Oral Oncol. 2023;147:106625.
PubMed Abstract available

WEIJERS JAM, de Bitter TJJ, Verhaegh GW, van Boxtel W, et al
Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.
Oral Oncol. 2023;147:106620.
PubMed

DOS SANTOS CMB, Cunha JLS, Barnabe LEG, Nonaka CFW, et al
Basal cell adenocarcinoma of the soft palate: A closer look for an exceedingly rare salivary gland tumor.
Oral Oncol. 2023;147:106617.
PubMed Abstract available

BARROS EF, Cunha JLS, de Sousa DP, Pereira RVS, et al
A destructive sinonasal organizing hematoma mimicking malignancy.
Oral Oncol. 2023;147:106619.
PubMed Abstract available

CAO LM, Zhong NN, Liu B, Sun YF, et al
A surge of hope: A case of lymph node hyperplasia after oral squamous cell carcinoma neoadjuvant immunotherapy.
Oral Oncol. 2023;147:106613.
PubMed

CORTINA LE, Meyer CD, Feng AL, Lin DT, et al
Depth of resection predicts loss of tongue tip sensation after partial glossectomy in oral tongue cancer: A pilot study.
Oral Oncol. 2023;147:106595.
PubMed Abstract available

LENG X, Zou L, Huang H, Wang Y, et al
Protrusion deviation due to intramuscular granular cell tumor of the tongue.
Oral Oncol. 2023;147:106581.
PubMed

DEWENTER I, Kumbrink J, Poxleitner P, Smolka W, et al
New insights into redox-related risk factors and therapeutic targets in oral squamous cell carcinoma.
Oral Oncol. 2023;147:106573.
PubMed Abstract available

DAYAN G, Bahig H, Fortin B, Filion E, et al
Predictors of prolonged treatment time intervals in oral cavity cancer.
Oral Oncol. 2023;147:106622.
PubMed Abstract available

SPENCE RN, Efthymiou V, Goss D, Varvares MA, et al
Margin distance in oral tongue cancer surgery: A systematic review of survival and recurrence outcomes.
Oral Oncol. 2023;147:106609.
PubMed Abstract available

RAMADAN S, Lee JJ, Wang R, Jackson RS, et al
Neighborhood socioeconomic status and race are associated with incidence disparities in oral cavity cancers.
Oral Oncol. 2023;147:106607.
PubMed Abstract available

GRAVES JP, Daher GS, Bauman MMJ, Moore EJ, et al
Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis.
Oral Oncol. 2023;147:106608.
PubMed Abstract available

CHENG JY, Hsu RC, Nieva JJ, Thomas JS, et al
Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report.
Oral Oncol. 2023;147:106597.
PubMed Abstract available

CORTINA LE, Moverman DJ, Zhao Y, Goss D, et al
Functional considerations between flap and non-flap reconstruction in oral tongue cancer: A systematic review.
Oral Oncol. 2023;147:106596.
PubMed Abstract available

November 2023

KALAVACHERLA S, Li V, Voora R, Victor M, et al
Factors associated with unknown primary status in head and neck squamous cell carcinoma.
Oral Oncol. 2023;148:106650.
PubMed Abstract available

ZHANG S, Zheng M, Tian H, Liu W, et al
Are immune checkpoint inhibitors ineffective in treating patients with head and neck squamous cell carcinoma aged 75 years or Older? A Meta-Analysis.
Oral Oncol. 2023;148:106632.
PubMed Abstract available

CHIU KW, Yu TP, Kao YS
A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.
Oral Oncol. 2023;148:106649.
PubMed Abstract available

DE SENA ACVP, de Arruda JAA, Felix FA, Tavares TS, et al
Oral carcinoma in situ in a middle-aged woman with systemic sclerosis: Report of a rare case and literature review.
Oral Oncol. 2023;148:106646.
PubMed Abstract available

HES C, Desilets A, Tonneau M, El Ouarzadi O, et al
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Oral Oncol. 2023;148:106623.
PubMed Abstract available

CHEN AM, Harris JP, Tjoa T, Haidar Y, et al
Racial disparities in the timely receipt of adjuvant radiotherapy for head and neck cancer.
Oral Oncol. 2023;147:106611.
PubMed Abstract available

TAKESHITA N, Enokida T, Okano S, Fujisawa T, et al
Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Oral Oncol. 2023;147:106615.
PubMed Abstract available

YU SM, Hsu CC, Hsueh SW, Hung CY, et al
Frailty assessment by two screening instruments in non-elderly patients with head and neck cancer.
Oral Oncol. 2023;147:106621.
PubMed Abstract available

HARRINGTON KJ, Cohen EEW, Soulieres D, Dinis J, et al
Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.
Oral Oncol. 2023;147:106587.
PubMed Abstract available

CHEN J, Shen X, Lian M, Fang J, et al
Parapharyngeal space ectopic thyroid with eutopic papillary thyroid cancer: A case report.
Oral Oncol. 2023;146:106577.
PubMed Abstract available

MOSS WJ, Kwon D, Wu N, Brett P, et al
Complete clinicoradiographic remission following immunotherapy treatment for an unresectable, multiply-recurrent oral verrucous carcinoma: A letter to the editor.
Oral Oncol. 2023;146:106567.
PubMed

KAUL P, Garg PK
Oral metronomic therapy as a resource-adaptive palliative strategy for recurrent/metastatic head and neck squamous cell cancers.
Oral Oncol. 2023;146:106576.
PubMed

DERMODY SM, McMichael BM, Bellile E, Marchiano EJ, et al
Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma.
Oral Oncol. 2023;146:106572.
PubMed Abstract available

ABDEL-HALIM CN, O'Byrne TJ, Graves JP, Akpala CO, et al
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
Oral Oncol. 2023;146:106569.
PubMed Abstract available

BARTEMES KR, Gochanour BR, Routman DM, Ma DJ, et al
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
Oral Oncol. 2023;146:106568.
PubMed Abstract available

HEI H, Luo Z, Zheng C, Gong W, et al
Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
Oral Oncol. 2023;146:106563.
PubMed Abstract available

WU S, Qi J, Abudunaibi M, Xu H, et al
Letter to the Editor regarding, "Gland-preserving surgery of benign parotid tumors via postauricular sulcus incision: Is it safe and effective with the scarless incision?".
Oral Oncol. 2023;146:106559.
PubMed

YU W, Ding C, Li K
Partial response to RC-48 as palliative treatment in a patient with locallocally advanced carcinoma ex pleomorphic adenoma harboring a HER2 mutation: a case report.
Oral Oncol. 2023;146:106541.
PubMed Abstract available

KWON JJY, Liu AQ, Milner TD, Prisman E, et al
Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer.
Oral Oncol. 2023;146:106537.
PubMed Abstract available

HERMSEN MA, Lechner M, Oliveira Ferrer L, Trama A, et al
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
Oral Oncol. 2023;146:106543.
PubMed Abstract available

SARAVANAN M, Arockiaraj J
Relationship between GLUT-1 and HIF-1alpha: Is it a friend or foe for studying the biological behaviour of head-and-neck tumorigenesis?
Oral Oncol. 2023;146:106553.
PubMed

SARODE GS, Sarode SC, Sharma N
Comment on "Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening".
Oral Oncol. 2023;147:106614.
PubMed

October 2023

ANSARI E, Ganry L, Van Cann EM, de Bree R, et al
Impact of low skeletal muscle mass on postoperative complications in head and neck cancer patients undergoing free flap reconstructive surgery - A systematic review and meta-analysis.
Oral Oncol. 2023;147:106598.
PubMed Abstract available

LIU ZQ, Zhao YN, Wu YS, Zhang BY, et al
Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma.
Oral Oncol. 2023;147:106583.
PubMed Abstract available

BATOOL S, Sethi RKV, Wang A, Dabekaussen K, et al
Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Oral Oncol. 2023;147:106584.
PubMed Abstract available

ROBERTI E, Merlano M, Ravanelli M, Alberti A, et al
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Oral Oncol. 2023;145:106540.
PubMed Abstract available

MYOKEN Y, Kawamoto T, Fujita Y, Toratani S, et al
Oral squamous cell carcinoma clinico-radiographically mimicking MRONJ.
Oral Oncol. 2023;145:106498.
PubMed

REVERDY T, Varnier R, de Talhouet S, Duplomb S, et al
Analysis of the benefit of salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck.
Oral Oncol. 2023;145:106533.
PubMed Abstract available

KEMNADE JO, Florez M, Sabichi A, Zhang J, et al
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
Oral Oncol. 2023;145:106536.
PubMed Abstract available

KALMEGH P, Sonone A, Hande A, Gawande M, et al
Epithelial-myoepithelial carcinoma with multiple recurrences: An unusual presentation.
Oral Oncol. 2023;145:106538.
PubMed Abstract available

JANG HB, Lee DH, Jung EK, Lee JK, et al
Diagnostic tips for parotid lymphoma.
Oral Oncol. 2023;145:106525.
PubMed Abstract available

OH KY, Hong SD
Infarction of basal cell adenoma of the parotid gland: First case report and literature review on CTNNB1 I35T mutations in salivary basal cell neoplasms.
Oral Oncol. 2023;145:106534.
PubMed Abstract available

SARAVANAN M, Sampath S, Arockiaraj J
The use of advanced transoral robotic surgery in the treatment of oropharynx squamous cell carcinoma: A modern alternative for open surgery.
Oral Oncol. 2023;145:106522.
PubMed

MISRA SR, Das R, Karthikeyan R
Quality of life in patients with oral squamous cell carcinoma: A critical assessment tool, sadly ignored!
Oral Oncol. 2023;145:106528.
PubMed

LIU MD, Xue XM, Al-Aroomi MA, Xiong JJ, et al
A novel flap design technique for subtotal tongue reconstruction with an "Individualized and Convenient Tongue Model".
Oral Oncol. 2023;145:106531.
PubMed Abstract available

SHIMODA H, Teshima M, Murase T, Nagao T, et al
Prognostic scores for patients with salivary adenoid cystic carcinoma without lymph node metastasis.
Oral Oncol. 2023;145:106491.
PubMed Abstract available

CHEN S, Yang Y, Wang R, Fang J, et al
Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis.
Oral Oncol. 2023;145:106479.
PubMed Abstract available

MISRA SR, Das R
Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
Oral Oncol. 2023;145:106511.
PubMed

BANAVAR G, Ogundijo O, Julian C, Toma R, et al
Detecting salivary host and microbiome RNA signature for aiding diagnosis of oral and throat cancer.
Oral Oncol. 2023;145:106480.
PubMed Abstract available

TURNER MT, Chung J, Noorkbash S, Topf MC, et al
Complications following salvage transoral robotic surgery with and without reconstruction: A systematic review of the literature.
Oral Oncol. 2023;145:106467.
PubMed Abstract available

September 2023

SHAIKH MH, Dawson A, Prokopec SD, Barrett JW, et al
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
Oral Oncol. 2023;146:106580.
PubMed Abstract available

CAVALIERI S, Platini F, Barretta F, Nuzzolese I, et al
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Oral Oncol. 2023;146:106579.
PubMed Abstract available

MALI SB
Role of in vivo imaging in Head and Neck cancer management.
Oral Oncol. 2023;146:106575.
PubMed Abstract available

CHOI SY, Shim J, Gu DE, Kim SY, et al
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening.
Oral Oncol. 2023;146:106571.
PubMed Abstract available

GUO J, He Y, Lin C, Jiang Q, et al
Integrating pretreatment MRI-detected nodal features and Epstein-Barr virus DNA to identify optimal candidates for intensity-modulated radiotherapy alone in patients with stage II nasopharyngeal carcinoma.
Oral Oncol. 2023;146:106574.
PubMed Abstract available

SINGH R, Song S
Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas.
Oral Oncol. 2023;146:106493.
PubMed Abstract available

SHAH R, Tyagi S, Liu C, Judson B, et al
Extra imaging beyond NCCN surveillance guidelines is cost effective for HPV- but not HPV+ oropharyngeal cancer.
Oral Oncol. 2023;146:106564.
PubMed

MANN JE, Smith JD, Kulkarni A, Foltin SK, et al
Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
Oral Oncol. 2023;146:106562.
PubMed Abstract available

JONASSON K, Sjovall J, Holmberg E, Beran M, et al
Squamous cell carcinoma of the mobile tongue in young adults: A Swedish head & neck cancer register (SweHNCR) population-based analysis of prognosis in relation to age and stage.
Oral Oncol. 2023;144:106485.
PubMed Abstract available

HOFMANN E, Priebe J, Rieke DT, Doll C, et al
Prognostic factors in surgically treated malignant salivary gland tumors.
Oral Oncol. 2023;144:106484.
PubMed Abstract available

DE FREITAS NEIVA LESSA A, Meirelles DP, Do Couto AM, Duarte Da Silva K, et al
Scales to graduate oral mucositis: What are the limitations?
Oral Oncol. 2023;144:106489.
PubMed Abstract available

NOROUZI A, Liaghat M, Bakhtiyari M, Noorbakhsh Varnosfaderani SM, et al
The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC).
Oral Oncol. 2023;144:106483.
PubMed Abstract available

SAHA S, Patil VM, Noronha V, Menon N, et al
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study.
Oral Oncol. 2023;144:106486.
PubMed Abstract available

ANDERSON EM, Luu M, Chung EM, Gay C, et al
Re-examining predictors of pathologic lymph node positivity in clinically node negative oral cavity cancer.
Oral Oncol. 2023;144:106490.
PubMed Abstract available

MALI SB
Molecular screening of head neck cancer.
Oral Oncol. 2023;144:106481.
PubMed Abstract available

FERNANDEZ FORNE A, Garcia Anaya MJ, Segado Guillot SJ, Plaza Andrade I, et al
Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review.
Oral Oncol. 2023;144:106488.
PubMed Abstract available

KIM S, Lee C, Kim H, Yoon SO, et al
Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Oral Oncol. 2023;144:106466.
PubMed Abstract available

CANAHUATE G, Wentzel A, Mohamed ASR, van Dijk LV, et al
Spatially-aware clustering improves AJCC-8 risk stratification performance in oropharyngeal carcinomas.
Oral Oncol. 2023;144:106460.
PubMed Abstract available

KIM DG, Choi SY
Regional and distal metastases of mammary analog secretory carcinoma in the parotid gland.
Oral Oncol. 2023;144:106463.
PubMed

SILVA LC, Faustino ISP, Ramos JC, Colafemina ACE, et al
The importance of early treatment of oral squamous cell carcinoma: Case report.
Oral Oncol. 2023;144:106442.
PubMed Abstract available

August 2023

VIEIRA GS, Perin MY, Figueiredo-Maciel T, Risuenho AJG, et al
Induction chemotherapy response of HPV-related multiphenotypic sinonasal carcinoma: First-ever reported therapeutic outcome and a brief literature review.
Oral Oncol. 2023;146:106555.
PubMed Abstract available

XU YC, Chen KH, Liang Y, Chen KQ, et al
Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis.
Oral Oncol. 2023;146:106554.
PubMed Abstract available

TASOULAS J, Schrank TP, Smith BD, Agala CB, et al
Time to treatment patterns of head and neck cancer patients before and during the Covid-19 pandemic.
Oral Oncol. 2023;146:106535.
PubMed Abstract available

CHARTERS E, Loy J, Wu R, Cheng K, et al
Feasibility study of intensive intervention using novel trismus device during adjuvant radiation for head and neck cancer: Restorabite(TM).
Oral Oncol. 2023;146:106558.
PubMed

AL-MANEI K, Sobkowiak MJ, Nagadia RH, Heymann R, et al
Mycobiota profile of oral fungal infections in head and neck cancer patients receiving radiotherapy: A 6-year retrospective MALDI-TOF mass spectrometry study.
Oral Oncol. 2023;146:106556.
PubMed Abstract available

PENAFORT PVM, Roza ALOC, Kussaba ST, de Brot Andrade L, et al
Exuberant clear cell odontogenic carcinoma of the mandible harboring EWSR1 rearrangement: Report of a rare case and a literature review.
Oral Oncol. 2023;143:106462.
PubMed Abstract available

DAROONPAN P, Ouchi R, Zhang C, Nagai S, et al
Personal immune profiles: Diversity and prognostic value for oral tongue squamous cell carcinoma evaluated by comprehensive immune parameter analyses with multiplex immunofluorescence.
Oral Oncol. 2023;143:106458.
PubMed Abstract available

QIU Z, Wu Z, Zhou X, Lin F, et al
Could definitive radiotherapy be a treatment option for lymphoepithelial carcinoma of major salivary gland: Comparison of clinical outcomes of upfront surgery and upfront chemoradiotherapy.
Oral Oncol. 2023;143:106443.
PubMed Abstract available

ZHANG L, Liao Y
Comment on: Efficacy of Anti-PD1 blockade in treating recurrent or metastatic nasopharyngeal cancer: A systematic review and meta-analysis.
Oral Oncol. 2023;143:106435.
PubMed

REGHUNADHAN P, Hegde S, Thakur S, Subash A, et al
Outcomes for recurrent oral cavity squamous cell carcinoma: A comprehensive outlook.
Oral Oncol. 2023;143:106440.
PubMed

URKEN ML, Yun J, Saturno MP, Greenberg LA, et al
Frozen Section Analysis in Head and Neck Surgical Pathology: A Narrative Review of the Past, Present, and Future of Intraoperative Pathologic Consultation.
Oral Oncol. 2023;143:106445.
PubMed Abstract available

BHAMBHANI C, Sandford E, Haring CT, Brummel C, et al
Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
Oral Oncol. 2023;143:106436.
PubMed Abstract available

July 2023

DOLL C, Bigus S, Hofmann E, Mrosk F, et al
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection.
Oral Oncol. 2023;145:106494.
PubMed Abstract available

GAN M, Harris JP, Truong A, Nabar R, et al
Timing of chemotherapy and radiation delivery for patients receiving chemoradiation for head and neck cancer: When does "concurrent" mean concurrent?
Oral Oncol. 2023;145:106492.
PubMed Abstract available

MULLER M, Li J, Giger R, Elicin O, et al
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge - A systematic review.
Oral Oncol. 2023;145:106529.
PubMed Abstract available

WEI F, Fang R, Lyu K, Liao J, et al
Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage.
Oral Oncol. 2023;145:106532.
PubMed Abstract available

WATSON E, El Maghrabi A, Lee JH, Pu J, et al
Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.
Oral Oncol. 2023;145:106527.
PubMed Abstract available

NEWMAN S, Cowart JH, Omar N, Martin E, et al
HPV-associated oropharyngeal Adenosquamous carcinoma with early metastatic disease detected by ctDNA.
Oral Oncol. 2023;145:106526.
PubMed Abstract available

HAN N, Zhou D, Ruan M, Yan M, et al
Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer.
Oral Oncol. 2023;145:106524.
PubMed Abstract available

NGAMPHAIBOON N, Chairoungdua A, Dajsakdipon T, Jiarpinitnun C, et al
Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2023;145:106520.
PubMed Abstract available

WANG G, Dong Z, Huang C, Du X, et al
The value of integrating tumor volume and plasma Epstein-Barr virus DNA load during sequential chemoradiotherapy for prognostic prediction and therapeutic guidance in high-risk locoregionally advanced nasopharyngeal carcinoma.
Oral Oncol. 2023;145:106500.
PubMed Abstract available

VIMALRAJ S, Sekaran S
Exploring the potential of MiRNAs as predictive biomarkers for radioresistance in nasopharyngeal carcinoma.
Oral Oncol. 2023;145:106521.
PubMed

YOKOTA Y, Hasegawa T, Yamakawa N, Rin S, et al
Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.
Oral Oncol. 2023;145:106519.
PubMed Abstract available

KO K, Takahashi T, Honda K, Horii A, et al
Avoiding total thyroidectomy for ectopic papillary thyroid carcinoma arising from the lateral neck.
Oral Oncol. 2023;145:106501.
PubMed

LI D, Li C, Shi S
Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.
Oral Oncol. 2023;145:106497.
PubMed

PENG WS, Xing X, Li YJ, Ding JH, et al
Prognostic nomograms for nasopharyngeal carcinoma with nodal features and potential indication for N staging system: Validation and comparison of seven N stage schemes.
Oral Oncol. 2023;144:106438.
PubMed Abstract available

ZENGA J, Awan M, Hadi Razeghi Kondelaji M, Hansen C, et al
Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer.
Oral Oncol. 2023;144:106487.
PubMed Abstract available

CHEPEHA DB, Esemezie AO, Philteos J, Brown DH, et al
Glossectomy for the treatment of oral cavity carcinoma: Quantitative, functional and patient-reported quality of life outcomes differ by four glossectomy defects.
Oral Oncol. 2023;142:106431.
PubMed Abstract available

SULTANIA M, Das Majumdar SK, Raghuram K, Ganapathy A, et al
A rare case of cavernous sinus thrombosis following oral squamous cell carcinoma - The etiology and management dilemma.
Oral Oncol. 2023;142:106421.
PubMed Abstract available

EVERTON ASSUNCAO RIBEIRO DA CO, Luz Santos I, Julia Andrade Pereira Soares M, Dos Reis de Paula I, et al
A case of metastatic NUT carcinoma of the nasal cavity.
Oral Oncol. 2023;142:106432.
PubMed

HOLCOMB AJ, Farrokhian N, Tolan C, Whiteford E, et al
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
Oral Oncol. 2023;142:106420.
PubMed Abstract available

June 2023

HE M, Gouda M, Gires O
EpCAM and EGFR crosstalk in the development of resistance towards Cetuximab treatment in head and neck cancer.
Oral Oncol. 2023;143:106465.
PubMed

YEUNG C, Meyers BM, Kartolo A
Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?
Oral Oncol. 2023;143:106444.
PubMed

KOYUNCU CF, Frederick MJ, Thompson LDR, Corredor G, et al
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients.
Oral Oncol. 2023;143:106459.
PubMed Abstract available

PANDIAR D, Nayanar SK, Nair V
Papillary thyroid carcinoma arising in thyroglossal duct cyst: A case report with long term follow-up.
Oral Oncol. 2023;143:106439.
PubMed

RUSSO E, Alessandri-Bonetti M, Costantino A, Festa BM, et al
Functional outcomes and complications of total glossectomy with laryngeal preservation and flap reconstruction: A systematic review and meta-analysis.
Oral Oncol. 2023;141:106415.
PubMed Abstract available

YU Y, Schoder H, Zakeri K, Chen L, et al
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity.
Oral Oncol. 2023;141:106400.
PubMed Abstract available

ZHANG L, Judd RT, Zhao S, Rygalski C, et al
Immediate resection of positive margins improves local control in oral tongue cancer.
Oral Oncol. 2023;141:106402.
PubMed Abstract available

May 2023

UMEMORI K, Ono K, Eguchi T, Kawai H, et al
EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
Oral Oncol. 2023;142:106433.
PubMed Abstract available

HIGGINSON JA, Breik O, Thompson AH, Ashrafian H, et al
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis.
Oral Oncol. 2023;142:106419.
PubMed Abstract available

WARNAKULASURIYA S
"Textbook outcome" as a quality metric of care in predicting survival from oral cancer.
Oral Oncol. 2023;141:106416.
PubMed

DING H, Wu C, Sun W, Zhan Q, et al
NUDT5-Determines the fate of head and neck squamous cell carcinoma cells under endoplasmic reticulum stress by catalyzing nuclear ATP production to promote DNA repair.
Oral Oncol. 2023;141:106397.
PubMed Abstract available

WANG Y, Gao Y, Yuan L, Zhang J, et al
Retraction notice to "Psychological needs and associated factors among perioperative patients with oral cancer" [Oral Oncol. 123 (2021) 105615].
Oral Oncol. 2023 May 5:106394. doi: 10.1016/j.oraloncology.2023.106394.
PubMed

RETTIG EM, Waterboer T, Sim E, Faden DL, et al
Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis.
Oral Oncol. 2023;141:106417.
PubMed

ALBERGA JM, Meijer J, Raghoebar GM, Langendijk JA, et al
Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions.
Oral Oncol. 2023;140:106392.
PubMed Abstract available

MIAO HJ, Sun SK, Tian YY, Yang YQ, et al
Oncologic safety of the pedicled submental island flap for reconstruction in oral tongue squamous cell carcinoma: An analysis of 101 cases.
Oral Oncol. 2023;140:106395.
PubMed Abstract available

REGHUNADHAN P, Hegde S, Thakur S, Subash A, et al
Preoperative prediction model in salvage surgery for oral cavity squamous cell carcinoma: Precision before Assertion.
Oral Oncol. 2023;140:106390.
PubMed

WANG T, Sun S, Zeng X, Li J, et al
ICI-based therapies: A new strategy for oral potentially malignant disorders.
Oral Oncol. 2023;140:106388.
PubMed Abstract available

XI Y, Negrao MV, Akagi K, Xiao W, et al
Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Oral Oncol. 2023;140:106372.
PubMed Abstract available

CAO Y, Yao H
Comment on: Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons.
Oral Oncol. 2023;140:106370.
PubMed

HUA Y, Huang X, Li C, Gao N, et al
An epulis-like camrelizumab related reactive cutaneous capillary endothelial proliferation (RCCEP) in the oral cavity: A case report.
Oral Oncol. 2023;140:106369.
PubMed Abstract available

ZHUGE L, Cai H, Huang Z, Wang S, et al
The optimal number of examined lymph nodes for accurate nodal staging and favorable prognosis of oral tongue squamous cell carcinoma.
Oral Oncol. 2023;140:106368.
PubMed Abstract available

April 2023

MISRA SR, Mohapatra SSG, Das R
Comment on "Elective neck dissection: Desideratum or overkill?".
Oral Oncol. 2023;141:106403.
PubMed

HUE J, Valinciute Z, Thavaraj S, Veschini L, et al
Multifactorial estimation of clinical outcome in HPV-associated oropharyngeal squamous cell carcinoma via automated image analysis of routine diagnostic H&E slides and neural network modelling.
Oral Oncol. 2023;141:106399.
PubMed Abstract available

BOSCOLO-RIZZO P, Tirelli G, Polesel J, Sia E, et al
TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
Oral Oncol. 2023;140:106398.
PubMed Abstract available

YANG TH, Xirasagar S, Cheng YF, Chen CS, et al
Trends in the incidence of head and neck cancer: A nationwide population-based study.
Oral Oncol. 2023;140:106391.
PubMed Abstract available

MERCHANT YP, Shah A
Elective neck dissection: Desideratum or overkill?
Oral Oncol. 2023;140:106389.
PubMed

ARAUJO ALD, Moraes MC, Perez-de-Oliveira ME, Silva VMD, et al
Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis.
Oral Oncol. 2023;140:106386.
PubMed Abstract available

LU H, Liu S, Xu W, Yang W, et al
"Cervical metastasis" of recurrent pleomorphic adenoma of the submandibular gland: A new perspective for multifocal of recurrent pleomorphic adenoma.
Oral Oncol. 2023;139:106355.
PubMed

PATEL ND, Cabrera CI, Fowler NM, Li S, et al
Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study.
Oral Oncol. 2023;139:106353.
PubMed Abstract available

MALI SB
Surveillance of head neck cancer: Case for personalized and standardized surveillance.
Oral Oncol. 2023;139:106354.
PubMed Abstract available

ARVIND B, Tazeen S, Thakur S, Rao VUS, et al
Upper oral cavity tumors: Is the risk of nodal metastasis different?
Oral Oncol. 2023;139:106356.
PubMed Abstract available

BIRKELAND AC, Kademani D, Moore MG, Blair EA, et al
Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons.
Oral Oncol. 2023;139:106341.
PubMed Abstract available

CHARTERS E, Cheng K, Dunn M, Clark JR, et al
Letter to the editor quantification of the force applied by the Therabite(R) Activeband.
Oral Oncol. 2023;139:106335.
PubMed

DAS R, Misra SR
Magnetic resonance imaging in the preoperative evaluation of depth of invasion in oral squamous carcinoma tongue: A few points to consider!
Oral Oncol. 2023;139:106337.
PubMed

COMER JC, Harris AB, Hess AO, Hitchcock KE, et al
Does lymphovascular invasion predict survival in oral cancer? A population-based analysis.
Oral Oncol. 2023;140:106387.
PubMed Abstract available

March 2023

ZUO N, Ma L, Liu T, Hu W, et al
Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
Oral Oncol. 2023;140:106367.
PubMed Abstract available

SAMPIERI C, Costantino A, Pirola F, Kim D, et al
Neoadjuvant chemotherapy combined with transoral robotic surgery for stage III and IV laryngeal and hypopharyngeal carcinomas.
Oral Oncol. 2023;140:106371.
PubMed Abstract available

HERNANDO-CALVO A, Mirallas O, Marmolejo D, Saavedra O, et al
Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients.
Oral Oncol. 2023;140:106364.
PubMed Abstract available

CHIEN CY, Wang CP, Lee LY, Lee SR, et al
Indications for elective neck dissection in cT1N0M0 oral cavity cancer according to the AJCC eight edition: A nationwide study.
Oral Oncol. 2023;140:106366.
PubMed Abstract available

LAMBERT T, Tasoulas J, Flores M, Sheth S, et al
Circulating tumor HPV DNA as an alternative method to determine HPV status in oropharyngeal squamous cell carcinoma.
Oral Oncol. 2023;140:106361.
PubMed Abstract available

SCHEFF NN, Nilsen ML, Li J, Harris AL, et al
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck.
Oral Oncol. 2023;140:106363.
PubMed Abstract available

BANOUB RG, Crippen MM, Fiorella MA, Ross HM, et al
Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma.
Oral Oncol. 2023;139:106360.
PubMed Abstract available

ZHANG L, Freeman T, Sun S, Bhateja P, et al
The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma.
Oral Oncol. 2023;139:106357.
PubMed

DE FELICE F
Docetaxel plus radiotherapy for head and neck cancer.
Oral Oncol. 2023;139:106359.
PubMed

ECONOMOPOULOU P, Spathis A, Kotsantis I, Maratou E, et al
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Oral Oncol. 2023;139:106358.
PubMed Abstract available

RAMBEAU A, Alidra A, Riot A
Metastatic lymphoepithelial carcinoma of the parotid gland: A case of prolonged response with platinum-gemcitabine regimen.
Oral Oncol. 2023;138:106315.
PubMed

MERCHANT YP, Shetty S, Jayaraj R, Gopalakrishnan D, et al
Depth of invasion in oral squamous carcinoma - More to this than meets the eye!
Oral Oncol. 2023;138:106327.
PubMed

DE SOUSA LG, Lazar Neto F, Dal Lago EA, Sikora A, et al
Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma.
Oral Oncol. 2023;138:106311.
PubMed Abstract available

SEKAR D
Authors reply referring to the article published in oral oncology entitled Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs.
Oral Oncol. 2023;138:106314.
PubMed

February 2023

LI SC, Deng SW, Sun XS, Lan KQ, et al
A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (>/=2 lines) anti-programmed death-1 monotherapy.
Oral Oncol. 2023;139:106336.
PubMed Abstract available

GUERLAIN J, Marhic A, Casiraghi O, Lumbroso J, et al
Occult nodal metastases in T1-T2cN0 oral squamous cell carcinoma: Correlation between sentinel node positivity and completion neck dissection analysis.
Oral Oncol. 2023;139:106338.
PubMed Abstract available

PARIKH AS, Yu VX, Flashner S, Okolo OB, et al
Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer.
Oral Oncol. 2023;138:106330.
PubMed Abstract available

XIAO Y, Mao L, Yang QC, Wang S, et al
CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer.
Oral Oncol. 2023;138:106331.
PubMed Abstract available

RYGALSKI CJ, Huttinger ZM, Zhao S, Brock G, et al
High surgical volume is associated with improved survival in head and neck cancer.
Oral Oncol. 2023;138:106333.
PubMed Abstract available

BALLAL Y, Gete M, Su J, O'Sullivan B, et al
The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.
Oral Oncol. 2023;138:106332.
PubMed Abstract available

BOOT PA, Mes SW, de Bloeme CM, Martens RM, et al
Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
Oral Oncol. 2023;137:106307.
PubMed Abstract available

HELLER MA, Nyirjesy SC, Balsiger R, Talbot N, et al
Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis.
Oral Oncol. 2023;137:106300.
PubMed Abstract available

SEKAR D
Authors reply to the comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Oral Oncol. 2023;137:106306.
PubMed

LASSCHE G, van Engen-van Grunsven ACH, van Hooij O, Aalders TW, et al
Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Oral Oncol. 2023;137:106297.
PubMed Abstract available

TERENZI V, Martellucci S, Dal Cortivo F, Stolfa A, et al
Malignant trichilemmal carcinoma misdiagnosed with parotid gland malignant tumor.
Oral Oncol. 2023;137:106303.
PubMed Abstract available

BURNHAM AJ, Boyce BJ, Kaka AS, El-Deiry MW, et al
Survival and functional outcomes after total glossectomy with total laryngectomy: Case series from a high-volume tertiary institution.
Oral Oncol. 2023;137:106301.
PubMed Abstract available

ZHANG S, Han X, Wang M, Shen X, et al
Comment on letters to the editor in oral oncology referring to microRNAs as therapeutic molecules for oral squamous cell carcinoma.
Oral Oncol. 2023;137:106298.
PubMed

MARTINS FMC, Neto TH, Martins SP, Mendes RB, et al
Metastasis to the oral cavity and jaw bones - A literature review about a case.
Oral Oncol. 2023;137:106276.
PubMed

January 2023

VAN BEERS MA, Schreuder WH, Balm AJM, van Dijk BAC, et al
Is locally advanced head and neck cancer 'increasing' in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share.
Oral Oncol. 2023;138:106316.
PubMed Abstract available

PELLET A, Bertolus C, Saintigny P, Foy JP, et al
Reliability of gene-expression profiling from tumor biopsy for refining neoadjuvant strategies in patients with head and neck squamous cell carcinoma.
Oral Oncol. 2023;138:106310.
PubMed Abstract available

ROBBINS Y, Friedman J, Redman J, Sievers C, et al
Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer.
Oral Oncol. 2023;138:106309.
PubMed Abstract available

WINNAND P, Ooms M, Heitzer M, Lammert M, et al
Real-time detection of bone-invasive oral cancer with laser-induced breakdown spectroscopy: A proof-of-principle study.
Oral Oncol. 2023;138:106308.
PubMed Abstract available

WU Z, Han Y, Wan Y, Hua X, et al
Oral microbiome and risk of incident head and neck cancer: A nested case-control study.
Oral Oncol. 2023;137:106305.
PubMed Abstract available

ARGYRIS PP, Saavedra F, Malz C, Stone IA, et al
Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
Oral Oncol. 2023;137:106304.
PubMed Abstract available

HALLER TJ, Yin XL, O'Byrne TJ, Moore EJ, et al
30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675).
Oral Oncol. 2023;137:106248.
PubMed Abstract available

SUNAVALA-DOSSABHOY G, Petti S
Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review.
Oral Oncol. 2023;136:106280.
PubMed Abstract available

ADEOYE J, Zheng LW, Thomson P, Choi SW, et al
Explainable ensemble learning model improves identification of candidates for oral cancer screening.
Oral Oncol. 2023;136:106278.
PubMed Abstract available

VOIZARD B, Khoury M, Saydy N, Nelson K, et al
Preoperative evaluation of depth of invasion in oral tongue squamous cell carcinoma: A systematic review and meta-analysis.
Oral Oncol. 2023;136:106273.
PubMed Abstract available

BOSSI P, Lorini L, Cosentini D, Grisanti S, et al
Is it time to tailor treatments in androgen receptor positive salivary gland cancers?
Oral Oncol. 2023;136:106274.
PubMed

YANG X, Liu L, Shen X, Shi L, et al
Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs.
Oral Oncol. 2023;136:106277.
PubMed Abstract available

PAN Y, Li Y, Yuan F, Lin Z, et al
A remarkable clinical response to immune checkpoint inhibitors of MSI-H high grade Mucoepidermoid carcinoma of the parotid gland with multiple metastases in the abdominal cavity.
Oral Oncol. 2023;136:106190.
PubMed

THARAKAN T, Marfowaa G, Akakpo K, Jackson R, et al
Multiple simultaneous free flaps for head and neck reconstruction: A multi-institutional cohort.
Oral Oncol. 2023;136:106269.
PubMed Abstract available

MERCHANT YP, Shetty CR, Shetty S
Hormonal therapy in salivary gland malignancies: A mirage or magic?
Oral Oncol. 2023;136:106267.
PubMed

ZHANG S, Deng Y, Ji T, Wang Y, et al
Overestimated risk of transformation in oral lichen planus: In reply with emphasis on natural history of proliferative verrucous leukoplakia.
Oral Oncol. 2023;136:106263.
PubMed

LAFUENTE-IBANEZ DE MENDOZA I, Aguirre-Urizar JM
Letter to the editor referring to the publication entitled ''A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!" by Das et al.
Oral Oncol. 2023;136:106262.
PubMed

LEE MK, Choi Y
Correlation between radiologic depth of invasion and pathologic depth of invasion in oral cavity squamous cell carcinoma: A systematic review and meta-analysis.
Oral Oncol. 2023;136:106249.
PubMed Abstract available

YEO BSY, Song HJJMD, Soong YL, Chua MLK, et al
Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis.
Oral Oncol. 2023;136:106242.
PubMed Abstract available

December 2022

IDA S, Takahashi H, Tada H, Mito I, et al
Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Oral Oncol. 2022;137:106296.
PubMed Abstract available

GHEENA S, Ezhilarasan D
Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients.
Oral Oncol. 2022;137:106282.
PubMed

DE FELICE F, Bossi P
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysis.
Oral Oncol. 2022;137:106275.
PubMed

PERES MA, Huihua L, Antunes JLF, Perea LME, et al
Time trend and Age-Period-Cohort analysis of potentially HPV-related oral and pharyngeal cancer incidence in Singapore between 1968 and 2017.
Oral Oncol. 2022;136:106272.
PubMed Abstract available

TAZEEN S, Suri H, Lakshmi R, Subash A, et al
Swallowing: A delayed milestone post-surgery in tongue cancers.
Oral Oncol. 2022;135:106238.
PubMed Abstract available

TAVERNA F, Alfieri S, Rebecca R, Giulia C, et al
Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
Oral Oncol. 2022;135:106229.
PubMed Abstract available

GAO X, Tian K, Huang L, Chen J, et al
Introducing the thin and ultrathin submental artery perforator flaps for precise reconstruction following T1-2 oral cavity cancer resection.
Oral Oncol. 2022;135:106234.
PubMed Abstract available

SMITH JD, Bellile EL, Ellsperman SE, Heft-Neal ME, et al
Prognostic value of CD103(+) tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
Oral Oncol. 2022;135:106226.
PubMed Abstract available

GUNAWARDENA DA, Howes D, Fleming S, Clark J, et al
Reconstruction of a maxillectomy and rhinectomy defect utilising a novel subperiosteal prosthesis and magnet-retained nasal prosthesis: A case report.
Oral Oncol. 2022;135:106222.
PubMed

MISSALE F, Marchi F, Iandelli A, Subramaniam N, et al
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer.
Oral Oncol. 2022;135:106210.
PubMed Abstract available

HENDRIKS T, Flukes S
Unknown primary Merkel cell carcinoma of the head and neck: Favourable outcomes with definitive radiotherapy.
Oral Oncol. 2022;135:106228.
PubMed

TAZEEN S, Lal R, Kp A, Thakur S, et al
Molecular and hormonal targets for malignant salivary gland tumors.
Oral Oncol. 2022;135:106225.
PubMed

DE KONING KJ, van Es RJJ, Breimer GE, de Bree R, et al
Response to: Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
Oral Oncol. 2022;135:106199.
PubMed

TANG KD, Weeramange CE, Vider J, Hartel G, et al
Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma.
Oral Oncol. 2022;135:106215.
PubMed

TAPIA M, Manji J, Dhillon K, Kleid S, et al
The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Oral Oncol. 2022;135:106213.
PubMed Abstract available

LASSCHE G, van Boxtel W, Aalders TW, van Hooij O, et al
Development and characterization of patient-derived salivary gland cancer organoid cultures.
Oral Oncol. 2022;135:106186.
PubMed Abstract available

MALI SB
Epigenetics: Promising journey so far but ways to go in head neck cancer.
Oral Oncol. 2022;135:106194.
PubMed Abstract available

SARAVANAN M
Constitutive activation of activator protein-1 as a cellular switch and its innovative role in the development of molecular targets for tongue squamous cell carcinoma treatment.
Oral Oncol. 2022;135:106198.
PubMed

KHADEMBASCHI D, Jafri M, Praveen P, Parmar S, et al
Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: A systematic review and pooled analysis.
Oral Oncol. 2022;135:106133.
PubMed Abstract available

PARK BJ, Mattox AK, Clayburgh D, Patel M, et al
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.
Oral Oncol. 2022;135:106183.
PubMed Abstract available

November 2022

MITO I, Takahashi H, Kawabata-Iwakawa R, Horikawa M, et al
Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.
Oral Oncol. 2022;136:106270.
PubMed Abstract available

KIRAN NAZEER P, Shaheen S, Shafique K, Sarfraz A, et al
The role of precision medicine in head and neck cancer: A systematic study of ongoing clinical trials.
Oral Oncol. 2022;136:106271.
PubMed

PENG Y, Liu Y, Shen G, Chen Z, et al
Improved accuracy of auto-segmentation of organs at risk in radiotherapy planning for nasopharyngeal carcinoma based on fully convolutional neural network deep learning.
Oral Oncol. 2022;136:106261.
PubMed Abstract available

MANZOOR H, Rasheed A, Zeen F, Sarfraz A, et al
Anti-PD-1 immunotherapy - Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study.
Oral Oncol. 2022;136:106266.
PubMed

LIU HC, Williamson CW, Zou J, Todd JR, et al
Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy.
Oral Oncol. 2022;136:106247.
PubMed Abstract available

CHAN JYK, Cheung MK, Lan L, Ng C, et al
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
Oral Oncol. 2022;135:106245.
PubMed Abstract available

KMIECIK M, Nogal P, Banaszewski J, Wierzbicka M, et al
Corrigendum to "Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report" [Oral Oncol. 134 (2022) 106135].
Oral Oncol. 2022 Nov 4:106233. doi: 10.1016/j.oraloncology.2022.106233.
PubMed

QUAN T, Guan W, Huang W, Cui C, et al
Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma.
Oral Oncol. 2022;135:106230.
PubMed Abstract available

BISHESHAR SK, van der Kamp MF, de Ruiter EJ, Ruiter LN, et al
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
Oral Oncol. 2022;135:106227.
PubMed Abstract available

ERRAZQUIN R, Page A, Sunol A, Segrelles C, et al
Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Oral Oncol. 2022;134:106184.
PubMed Abstract available

CHIDAMBARAM S, Hong SA, Simpson MC, Osazuwa-Peters N, et al
Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
Oral Oncol. 2022;134:106132.
PubMed Abstract available

AROSIO AD, Bernasconi DP, Valsecchi MG, Pacifico C, et al
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers.
Oral Oncol. 2022;134:106123.
PubMed Abstract available

CONTRERA KJ, Zafereo ME, Yaniv D, Roberts DB, et al
Outcomes for recurrent oral cavity squamous cell carcinoma.
Oral Oncol. 2022;134:106127.
PubMed Abstract available

DAS R, Misra SR, Pradhan S
A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!
Oral Oncol. 2022;134:106126.
PubMed

LIU Y, Bilodeau E, Pollack B, Batmanghelich K, et al
Automated detection of premalignant oral lesions on whole slide images using convolutional neural networks.
Oral Oncol. 2022;134:106109.
PubMed Abstract available

TITINCHI F, Sallies M, Wu HT
Mucoepidermoid carcinoma ex pleomorphic adenoma: A rare diagnostically challenging entity.
Oral Oncol. 2022;134:106112.
PubMed Abstract available

RAMASUBBU K, Devi Rajeswari V
A novel target approach for epithelial-mesenchymal transitioning oral squamous cell carcinoma and their involvement of PI3K/Akt/mTOR and Hedgehog signaling pathway.
Oral Oncol. 2022;134:106119.
PubMed

VILLEGAS KM, Paparella ML
Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature.
Oral Oncol. 2022;134:106068.
PubMed Abstract available

YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
Oral Oncol. 2022;134:106120.
PubMed

CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC).
Oral Oncol. 2022;134:106124.
PubMed

YASASVE M, Saravanan M
Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma.
Oral Oncol. 2022;134:106104.
PubMed

ROH JL
Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland.
Oral Oncol. 2022;134:106103.
PubMed Abstract available

SEKAR D, Selvakumar SC, Auxzilia Preethi K
Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
Oral Oncol. 2022;134:106106.
PubMed

ELUMALAI P, Ezhilarasan D
Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.
Oral Oncol. 2022;134:106100.
PubMed

MANJUSHA M, Saravanan M
Oropharyngeal cancer associated with sarcopenic obesity and sarcopenic weight loss.
Oral Oncol. 2022;134:106101.
PubMed

FITZGERALD CWR, Davies JC, de Almeida JR, Rich JT, et al
Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study.
Oral Oncol. 2022;134:106089.
PubMed Abstract available

DE LUCA P, Scarpa A, Viola P, Motta G, et al
Collision tumors of the larynx: A retrospective single-center case series of an extremely rare phenomenon.
Oral Oncol. 2022;134:106096.
PubMed

TOPKAN E, Somay E, Yilmaz B, Kucuk A, et al
Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
Oral Oncol. 2022;134:106098.
PubMed

KAJO K, Othman BK, Kajova Machalekova K
Sclerosing Warthin-like mucoepidermoid carcinoma of the salivary gland.
Oral Oncol. 2022;134:106090.
PubMed

SEKARAN S, Ganapathy D
Salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders.
Oral Oncol. 2022;134:106065.
PubMed

FESTA BM, Costantino A, Ferreli F, Spriano G, et al
The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores: Avoiding the wrong conclusion.
Oral Oncol. 2022;134:106071.
PubMed

WEINBERGER JM, Abd El Qadir N, Hirshoren N
Double trouble: A cohort study of re-irradiation and laryngectomy - Severity of and risk for pharyngocutaneous fistula.
Oral Oncol. 2022;134:106069.
PubMed Abstract available

DE BREE R, Leemans CR
When to perform a paratracheal lymph node dissection during total laryngectomy?
Oral Oncol. 2022;134:106048.
PubMed

WU B, Shen L, Peng G, Li Y, et al
Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing.
Oral Oncol. 2022;135:106218.
PubMed Abstract available

HUANG J, Harris E, Lorch J
Vaccination as a therapeutic strategy for Nasopharyngeal carcinoma.
Oral Oncol. 2022;135:106083.
PubMed Abstract available

October 2022

XUE S, Song G, Zhu Y, Zhang N, et al
The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis.
Oral Oncol. 2022;135:106231.
PubMed Abstract available

KAO DD, Ferrandino RM, Bauml JM, Marshall DC, et al
Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck.
Oral Oncol. 2022;135:106216.
PubMed Abstract available

ZHU L, Li M, Tang G, Shi L, et al
Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders - Reply.
Oral Oncol. 2022;135:106224.
PubMed

DENNIS MJ, Sacco AG, Qi Y, Bykowski J, et al
A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Oral Oncol. 2022;135:106219.
PubMed Abstract available

GOVINDARASU M, Prathap L, Govindasamy R
Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway.
Oral Oncol. 2022;135:106221.
PubMed

CHABRILLAC E, Lebars S, Breuskin I, Thariat J, et al
Pregnancy-associated head and neck cancer:a partnership between theCORASSO patient association and theREFCOR physician networkto study a pathology of extremely rare occurrence.
Oral Oncol. 2022;135:106223.
PubMed

OLAWUNI FO, Sauer AB, Daher GS, Douse DM, et al
The reporting and representation of sex and gender in head and neck cancer clinical trials.
Oral Oncol. 2022;135:106217.
PubMed

SUNDRAMOORTHY AK, Atchudan R, Arya S
Utilization of Raman spectroscopy in biochemical fingerprint analysis for oral cancer screening and diagnosis.
Oral Oncol. 2022;135:106192.
PubMed

ZHU L, Deng Y, Ji T, Zhou H, et al
Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
Oral Oncol. 2022;135:106196.
PubMed

MANJUSHA M, Saravanan M
Development of novel electrochemical based nano-biosensors for the diagnosis of oral potentially malignant disorders and oral carcinoma.
Oral Oncol. 2022;135:106197.
PubMed

SEKAR AA, Veeraraghavan VP, Raj AT, Patil S, et al
Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer.
Oral Oncol. 2022;135:106195.
PubMed

GURMEET SINGH A, Sathe P, Roy S, Thiagrajan S, et al
Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth?
Oral Oncol. 2022;135:106201.
PubMed Abstract available

KRISHNAMOORTHY K, Priya Veeraraghavan V, Jayaraman S
E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma.
Oral Oncol. 2022;135:106193.
PubMed

ZHU S, Zhang F, Zhao G, Zhang X, et al
Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019.
Oral Oncol. 2022;134:106189.
PubMed Abstract available

LIU W, Ji T, Zhang C, Zhou Q, et al
Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
Oral Oncol. 2022;134:106129.
PubMed Abstract available

YU C, Zhou Z
Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
Oral Oncol. 2022;133:106057.
PubMed

FEENEY L, Hapuarachi B, Adderley H, Rack S, et al
Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
Oral Oncol. 2022;133:106028.
PubMed Abstract available

MORING MM, Mast H, Wolvius EB, Verduijn GM, et al
Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
Oral Oncol. 2022;133:106056.
PubMed Abstract available

AUXZILIA PREETHI K, Chandralekha Selvakumar S, Sekar D
MicroRNAs and it's targets in the treatment of salivary adenoid cystic carcinoma.
Oral Oncol. 2022;133:106053.
PubMed

KEY S, Chia C, Hasan Z, Sundaresan P, et al
Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
Oral Oncol. 2022;133:106052.
PubMed Abstract available

ANGEL GONZALEZ-MOLES M, Ramos-Garcia P
Overestimated risk of transformation in oral lichen planus: In reply.
Oral Oncol. 2022;133:106045.
PubMed

DE KONING KJ, van Es RJJ, Klijn RJ, Breimer GE, et al
Application and accuracy of ultrasound-guided resections of tongue cancer.
Oral Oncol. 2022;133:106023.
PubMed Abstract available

NGUYEN ML, Hsieh ML, Henson C, Krempl G, et al
Neoadjuvant QUAD shot for downstaging or temporizing locally advanced oral cavity cancer prior to definitive surgery.
Oral Oncol. 2022;133:106029.
PubMed Abstract available

SARAVANAN M, Kolade Omole R, Torimiro N
Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment.
Oral Oncol. 2022;133:106021.
PubMed

CAI X, Zhang J, Zhang H, Li T, et al
Overestimated risk of transformation in oral lichen planus.
Oral Oncol. 2022;133:106025.
PubMed Abstract available

SIVAPERUMAL P, Kamala K
Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer.
Oral Oncol. 2022;133:106020.
PubMed

HENG Y, Yang Z, Lin J, Liu Q, et al
Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Oral Oncol. 2022;134:106185.
PubMed Abstract available

September 2022

MORSE RT, Beaty B, Scanga L, Blumberg J, et al
Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
Oral Oncol. 2022;134:106131.
PubMed Abstract available

ZHU GL, Fang XL, Yang KB, Tang LL, et al
Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load.
Oral Oncol. 2022;134:106140.
PubMed Abstract available

XUE F, Ou D, Ou X, Zhou X, et al
Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma.
Oral Oncol. 2022;134:106139.
PubMed Abstract available

SANKAR S
New insights into CAR T-cell therapy for recurrent head and neck squamous cell carcinoma.
Oral Oncol. 2022;134:106137.
PubMed

KMIECIK M, Nogal P, Wierzbicka M, Jackowska J, et al
Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report.
Oral Oncol. 2022;134:106135.
PubMed Abstract available

GUPTA T, Kannan S, Ghosh-Laskar S, Agarwal JP, et al
Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?
Oral Oncol. 2022;134:106130.
PubMed Abstract available

HITT R, Mesia R, Lozano A, Iglesias Docampo L, et al
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
Oral Oncol. 2022;134:106087.
PubMed Abstract available

ZHANG J, Wu HY, Lu Q, Shan XF, et al
Effects of personalized swallowing rehabilitation in patients with oral cancer after free flap transplantation: A cluster randomized controlled trial.
Oral Oncol. 2022;134:106097.
PubMed Abstract available

PATIL V, Kumar S, Noronha V, Menon N, et al
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.
Oral Oncol. 2022;134:106085.
PubMed

SARODE GS, Anand R, Sharma NK, Sarode SC, et al
Hot and cold tumor: Recent developments and perspectives on oral cancer.
Oral Oncol. 2022;134:106114.
PubMed

BEOM HEO D, Piao Y, Hee Lee J, Ju SH, et al
Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
Oral Oncol. 2022;134:106115.
PubMed Abstract available

SAHNI V, Kumar A, Gupta S, Sharma S, et al
Metformin and oral cancer.
Oral Oncol. 2022;134:106125.
PubMed

TOBIAS MAS, Nogueira BP, Santana MCS, Pires RG, et al
Artificial intelligence for oral cancer diagnosis: What are the possibilities?
Oral Oncol. 2022;134:106117.
PubMed Abstract available

SHREE HARINI K, Ezhilarasan D, Elumalai P
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment.
Oral Oncol. 2022;134:106113.
PubMed

NONG T, Medrano T, Marrero C, Rubens M, et al
Radiation induced taste changes in head and neck cancer - differential impact of treatment factors.
Oral Oncol. 2022;134:106105.
PubMed

MUTHUKRISHNAN L
"TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)".
Oral Oncol. 2022;134:106118.
PubMed

MONY U, Priya Veeraraghavan V
"Rules" to the genetic progression of tumours deciphered: Is it time to think differently in treating oral cancer patients?
Oral Oncol. 2022;134:106111.
PubMed

PRASAD M, Jayaraman S, Rajagopal P, Veeraraghavan VP, et al
Apoptosis regulating CircRNAs: Emerging role in oral cancer therapeutics.
Oral Oncol. 2022;134:106107.
PubMed

DE WIT JG, van Schaik JE, Voskuil FJ, Vonk J, et al
Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery.
Oral Oncol. 2022;134:106099.
PubMed Abstract available

VILASECA I, Xavier Aviles-Jurado F, Lehrer E, Valduvieco I, et al
CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy.
Oral Oncol. 2022;134:106088.
PubMed Abstract available

YUAN H, Yan M, Liang X, Liu W, et al
Decoding the associations between cell functional states in head and neck cancer based on single-cell transcriptome.
Oral Oncol. 2022;134:106110.
PubMed Abstract available

BALACHANDER K, Vijayashree Priyadharsini J, Paramasivam A
Advances in oral cancer early diagnosis and treatment strategies with liquid biopsy-based approaches.
Oral Oncol. 2022;134:106108.
PubMed

TAKENAKA Y, Takemoto N, Otsuka T, Nishio M, et al
Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study.
Oral Oncol. 2022;132:106018.
PubMed Abstract available

LIU AQ, Deane EC, Heffernan A, Ji Y, et al
Patient-reported outcomes and morbidity after head and neck reconstructions: An evaluation of fibular and scapular free flaps.
Oral Oncol. 2022;132:106019.
PubMed Abstract available

SHAH HP, Cohen O, Sukys J, Dibble J, et al
The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores.
Oral Oncol. 2022;132:106006.
PubMed Abstract available

AMITH K P, V Lal R, Lakshmi Pandey R, Thakur S, et al
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
Oral Oncol. 2022;132:106014.
PubMed

CHABRILLAC E, Jackson R, Mattei P, D'Andrea G, et al
Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: A systematic review and meta-analysis.
Oral Oncol. 2022;132:106017.
PubMed Abstract available

DAS R, Satya Sai Reddy Gontu G, Das K, Das A, et al
Validation of ATA guidelines for Indian population: Do ATA guidelines have an impact on management of DTC patients in Indian population - A 5 year retrospective cohort analysis.
Oral Oncol. 2022;132:106016.
PubMed

SOARES CD, Santana T, Lacerda de Souza L, Paes de Almeida O, et al
Intraductal carcinoma of the submandibular gland: A case report.
Oral Oncol. 2022;132:106010.
PubMed

K P A, Thakur S, Hanagvadi S, Siva Bharani KSN, et al
"Haemophilia A" - Presenting with oral squamous cell carcinoma diagnosis and management strategies.
Oral Oncol. 2022;132:105994.
PubMed Abstract available

TASSONE P, Caruso C, White M, Tavares Dos Santos H, et al
The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma.
Oral Oncol. 2022;132:106002.
PubMed Abstract available

MARINHO MFP, Marinho MCFL, de Andrade BAB, Pinto MAVR, et al
Oral squamous cell carcinoma clinically resembling BRONJ.
Oral Oncol. 2022;132:105974.
PubMed

YANG X, Yang X, Ji T, Zhou Q, et al
A bibliometric analysis of the papers on oral potentially malignant disorder in Oral Oncology.
Oral Oncol. 2022;132:105996.
PubMed

FERRER-SANCHEZ A, Bagan J, Vila-Frances J, Magdalena-Benedito R, et al
Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning.
Oral Oncol. 2022;132:105967.
PubMed Abstract available

CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
Response to the comment on "The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations".
Oral Oncol. 2022;132:105984.
PubMed

CABRAL RAMOS J, Cesar Silva L, Schausltz Pereira Faustino I, Carolina Evangelista Colafemina A, et al
A rare case of squamous cell carcinoma of the gingiva: A diagnostic challenge.
Oral Oncol. 2022;132:105995.
PubMed Abstract available

DENG W, Zhao G, Li Z, Yang L, et al
Recovery pattern analysis of swallowing function in patients undergoing total glossectomy and hemiglossectomy.
Oral Oncol. 2022;132:105981.
PubMed Abstract available

JACOBS CD, Barak I, Jung SH, Rocke DJ, et al
Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.
Oral Oncol. 2022;132:105955.
PubMed Abstract available

SIEVERT M, Oetter N, Mantsopoulos K, Gostian AO, et al
Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma.
Oral Oncol. 2022;132:105978.
PubMed Abstract available

August 2022

CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
Non-coding RNAs influencing anti PD-1 immunotherapy in head and neck squamous cell carcinoma (HNSCC).
Oral Oncol. 2022;134:106092.
PubMed

YADALAM PK, Anegundi RV, Ramadoss R, Joseph B, et al
Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain.
Oral Oncol. 2022;134:106094.
PubMed

SEMPRINI J
Oral cancer screening prevalence in low-income adults before and after the ACA.
Oral Oncol. 2022;134:106055.
PubMed Abstract available

PAZHANI J, Veeraraghavan VP, Jayaraman S
Aurora kinase in oral cancer: A potential therapeutic target to improve treatment efficiency.
Oral Oncol. 2022;134:106093.
PubMed

KRUTZ M, Acharya P, Chissoe G, Raj V, et al
Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival.
Oral Oncol. 2022;134:106072.
PubMed Abstract available

HEMPENIUS MA, Bisheshar SK, Slagter-Menkema L, van der Kamp MF, et al
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma.
Oral Oncol. 2022;134:106086.
PubMed Abstract available

VAISH R, Mittal N, Mahajan A, Rane SU, et al
Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!
Oral Oncol. 2022;134:106070.
PubMed Abstract available

MUTHUPANDIAN S, Muralidharan M, Madhavan Y, Hariharan NM, et al
Prospective role of salivary MicroRNA for early detection - personalized therapy of head and neck squamous cell carcinoma.
Oral Oncol. 2022;134:106063.
PubMed

PARAMASIVAM A
Circulating circular RNAs: Novel potential biomarkers and therapeutic targets for oral cancer.
Oral Oncol. 2022;134:106067.
PubMed

EZHILARASAN D, Shree Harini K
Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy.
Oral Oncol. 2022;133:106066.
PubMed

PRASAD M, Veeraraghavan VP, Jayaraman S
Tumorigenic potential of GLUT4: A therapeutic target for head and neck squamous cell carcinoma.
Oral Oncol. 2022;133:106061.
PubMed

YU C, Zhou Z
Relationship between young non-smokers and oral cancer: What can we learn?
Oral Oncol. 2022;133:106064.
PubMed

REKHA K, Venkidasamy B, Govindasamy R, Neralla M, et al
Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer.
Oral Oncol. 2022;133:106060.
PubMed

BALACHANDER K, Abilasha R, Priyadharsini JV, Balamurugan R, et al
Targeting mitochondria for apoptosis in oral cancer: Therapeutic potential and obstacles.
Oral Oncol. 2022;133:106059.
PubMed

SARODE GS, Kumari N, Gophane R, Ghone U, et al
Trends and prospects in oral cancer vaccine.
Oral Oncol. 2022;133:106051.
PubMed

MA SJ, Yu H, Khan M, Yu B, et al
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
Oral Oncol. 2022;133:106054.
PubMed Abstract available

VERDONCK-DE LEEUW I, Dawson C, Licitra L, Eriksen JG, et al
European Head and Neck Society recommendations for head and neck cancer survivorship care.
Oral Oncol. 2022;133:106047.
PubMed Abstract available

LU HJ, Peng CY, Tseng HC, Hsin CH, et al
Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
Oral Oncol. 2022;131:105951.
PubMed Abstract available

ZANOLETTI E, Tealdo G, Franz L, Cazzador D, et al
From "Extended total parotidectomy" to "Temporo-parotid resection" for locally advanced parotid tumors: Outlining a shift in surgical perspective.
Oral Oncol. 2022;131:105975.
PubMed

STANBOULY D, Philipone E, Morlandt AB, Kaleem A, et al
Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes.
Oral Oncol. 2022;131:105952.
PubMed Abstract available

SIVAPERUMAL P, Sekaran S, Kamala K, Ganapathy D, et al
Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
Oral Oncol. 2022;131:105971.
PubMed

WU Y, Koyuncu CF, Toro P, Corredor G, et al
A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study.
Oral Oncol. 2022;131:105942.
PubMed Abstract available

HAN N, Li X, Wang Y, Li H, et al
HIF-1alpha induced NID1 expression promotes pulmonary metastases via the PI3K-AKT pathway in salivary gland adenoid cystic carcinoma.
Oral Oncol. 2022;131:105940.
PubMed Abstract available

DONA MG, Rollo F, Pichi B, Moretto S, et al
Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
Oral Oncol. 2022;131:105947.
PubMed

July 2022

DASSE R, Dupin C, Gorphe P, Temam S, et al
Proposal for an algorithm to avoid neck dissection during salvage total laryngectomy. A GETTEC multicentric study.
Oral Oncol. 2022;133:106026.
PubMed Abstract available

CHOW JCH, Lee AWM, Wong CHL, Ng WT, et al
Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
Oral Oncol. 2022;133:106031.
PubMed Abstract available

KRISHNAN M, Venkidasamy B
PEITC: A prospective natural metabolite in oral cancer treatment.
Oral Oncol. 2022;133:106044.
PubMed

YU C, Zhou Z
Assessment of oral dysfunction after oral cancer treatment.
Oral Oncol. 2022;133:106046.
PubMed

SARODE GS, Sarode SC, Kumari N, Gophane R, et al
FAP-targeted imaging in oral cancer: Critical viewpoints.
Oral Oncol. 2022;133:106024.
PubMed

YASASVE M, Manjusha M, Saravanan M
Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.
Oral Oncol. 2022;133:106027.
PubMed

KONO M, Saito S, Egloff AM, Allen CT, et al
The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.
Oral Oncol. 2022;132:106012.
PubMed Abstract available

MELO G, Silva CAB, Hague A, Parkinson EK, et al
Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
Oral Oncol. 2022;132:105979.
PubMed Abstract available

KUMARESAN V, Sivaperumal P, Smiline Girija AS
Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells - Multifunctional therapeutic approach against oral cancer.
Oral Oncol. 2022;132:106013.
PubMed

RENU K, Veeraraghavan VP, Raj A T, Patil S, et al
The peroxisome proliferator-activated receptor-alpha (PPAR-alpha): A new therapeutic target for oral cancer.
Oral Oncol. 2022;132:106007.
PubMed

ALLEN JL, Hames RA, Mastroianni NM, Greenstein AE, et al
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
Oral Oncol. 2022;132:106008.
PubMed Abstract available

SARODE GS, Kumari N, Sarode SC
Oral cancer histopathology images and artificial intelligence: A pathologist's perspective.
Oral Oncol. 2022;132:105999.
PubMed

DE VRIES J, Poelman A, Sidorenkov G, Festen S, et al
The association of frailty and outcomes of geriatric assessment with acute radiation-induced toxicity in patients with head and neck cancer.
Oral Oncol. 2022;130:105933.
PubMed Abstract available

RIBEIRO MFA, Oliveira MCM, Leite AC, Bruzinga FFB, et al
Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review.
Oral Oncol. 2022;130:105936.
PubMed Abstract available

KAZEMIAN E, Solinski M, Adams W, Moore M, et al
The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
Oral Oncol. 2022;130:105937.
PubMed Abstract available

JAYARAMAN S, Sekar R, Veeraraghavan VP, Raj AT, et al
MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy.
Oral Oncol. 2022;130:105950.
PubMed

FANG Y, Peng Z, Wang Y, Gao K, et al
Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
Oral Oncol. 2022;130:105945.
PubMed Abstract available

MIN Y, Feng Y, He D, Zeng X, et al
Is Age >/= 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
Oral Oncol. 2022;130:105938.
PubMed Abstract available

LI C, Zhang Q, Sun K, Jia H, et al
Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
Oral Oncol. 2022;130:105941.
PubMed Abstract available

PONNIAH I
"In response to "Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia".
Oral Oncol. 2022;130:105944.
PubMed

MENDONCA P, Sunny SP, Mohan U, Birur N P, et al
Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
Oral Oncol. 2022;130:105877.
PubMed Abstract available

KIL WJ
Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative intervention was available during COVID-19 pandemic.
Oral Oncol. 2022;130:105930.
PubMed

SELVAKUMAR SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, et al
MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Oral Oncol. 2022;130:105925.
PubMed

KIONG KL, Moreno A, Vu CN, Zheng G, et al
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
Oral Oncol. 2022;130:105906.
PubMed Abstract available

MA P, Shen HY, Chen DS, Lu ZY, et al
Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
Oral Oncol. 2022;130:105905.
PubMed

TANG R, Mao S, Liu S, Li Z, et al
Types of endoscopic surgical approaches for benign parapharyngeal space tumors.
Oral Oncol. 2022;130:105875.
PubMed

DOLL C, Mrosk F, Wuester J, Runge AS, et al
Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
Oral Oncol. 2022;130:105898.
PubMed Abstract available

MAZEROLLE P, Fuchsmann C, Schultz P, Benmoussa N, et al
Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.
Oral Oncol. 2022;130:105896.
PubMed Abstract available

VIGARIOS E, Warnakulasuriya S, Piau A, Giraudeau N, et al
Early detection of oral malignancies may involve the development of tele-expertise in dentistry.
Oral Oncol. 2022;130:105904.
PubMed

YANG X, Zhou T, Ji T, Jia H, et al
Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
Oral Oncol. 2022;130:105901.
PubMed

JAYASEELAN VP, A S SG, Arumugam P
Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Oral Oncol. 2022;130:105874.
PubMed

EZHILARASAN D, Shree Harini K, Lakshmi T
Osteopontin: A reliable diagnostic marker and an attractive therapeutic target in oral cancers.
Oral Oncol. 2022;132:106005.
PubMed

June 2022

MISRA SR, Das R
Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!
Oral Oncol. 2022;132:105998.
PubMed

BALACHANDER K, Paramasivam A
Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
Oral Oncol. 2022;132:105997.
PubMed

BABU S, Krishnan M, Priya Veeraraghavan V, Jayaraman S, et al
Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma.
Oral Oncol. 2022;132:105993.
PubMed

ALESSANDRINI L, Ferrari M, Taboni S, Sbaraglia M, et al
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
Oral Oncol. 2022;132:105982.
PubMed Abstract available

SHREE HARINI K, Ezhilarasan D, Lakshmi T
Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
Oral Oncol. 2022;132:105983.
PubMed

REVATHI D, Dhanraj G, Ashok V
Immune check point inhibitors: A promising therapeutic approach in oral cancer.
Oral Oncol. 2022;132:105977.
PubMed

SEKARAN S, Pitchaiah S, Ganapathy D
Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?
Oral Oncol. 2022;131:105973.
PubMed

ZONG J, Ji P, Lin C, Zhang R, et al
Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
Oral Oncol. 2022;131:105972.
PubMed Abstract available

BALACHANDER K, Paramasivam A
Ferroptosis: An emerging therapeutic target for oral cancer.
Oral Oncol. 2022;131:105970.
PubMed

GANAPATHY D, Sekaran S, Pitchaiah S
Is prognostic monitoring of high-risk populations at risk for oral cancer necessary after infection with COVID-19?
Oral Oncol. 2022;131:105968.
PubMed

LUO HD, Xia FJ, Wu JH, Yi B, et al
Efficacy of chemoradiotherapy in survival of stage nasopharyngeal carcinoma and establishment of a prognostic model.
Oral Oncol. 2022;131:105927.
PubMed Abstract available

SHREE HARINI K, Ezhilarasan D, Lakshmi T
Patient derived tumour organoids: An emerging strategy in oral cancer research and therapeutics.
Oral Oncol. 2022;131:105954.
PubMed

VARGHESE BT, Nair SP, Janardhan D
Transglottic intralaryngeal papillary thyroid carcinoma.
Oral Oncol. 2022;131:105935.
PubMed Abstract available

YANG Z, Liao J, Schumaker L, Carter-Cooper B, et al
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
Oral Oncol. 2022;131:105939.
PubMed Abstract available

SHREE HARINI K, Ezhilarasan D
Promising autophagy inhibitors: Therapeutic implications in oral cancer.
Oral Oncol. 2022;131:105948.
PubMed

DE FELICE F
FLASH radiotherapy in head and neck cancer: Myth or reality?
Oral Oncol. 2022;131:105953.
PubMed

VIJAYASHREE PRIYADHARSINI J, Anitha P
Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions.
Oral Oncol. 2022;129:105902.
PubMed

LEBOUCHER A, Sotton S, Gambin Flandrin I, Magne N, et al
Head and neck radiotherapy-induced carotid toxicity: Pathophysiological concepts and clinical syndromes.
Oral Oncol. 2022;129:105868.
PubMed Abstract available

BALACHANDER K, Paramasivam A
Mitophagy: A therapeutic target for oral squamous cell carcinoma.
Oral Oncol. 2022;129:105881.
PubMed

FERRELI F, Pirola F, Di Santo D, De Virgilio A, et al
A critical analysis of the classifications of squamous cell carcinoma of the nasal vestibule.
Oral Oncol. 2022;129:105880.
PubMed

PAQUIN R, Gill B, Martin E, Byrd JK, et al
Base of tongue neuroendocrine carcinoma: A case report.
Oral Oncol. 2022;129:105780.
PubMed Abstract available

May 2022

JAYARAMAN S, Pazhani J, PriyaVeeraraghavan V, Raj AT, et al
PCNA and Ki67: Prognostic proliferation markers for oral cancer.
Oral Oncol. 2022;130:105943.
PubMed

BALACHANDER K, Paramasivam A
Selective autophagy as a potential therapeutic target for oral cancer.
Oral Oncol. 2022;130:105934.
PubMed

PATIL VM, Kolkur M, Kumar Chinthala S, Waratkar G, et al
Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
Oral Oncol. 2022;130:105908.
PubMed

UEDA Y, Okano S, Enokida T, Fujisawa T, et al
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
Oral Oncol. 2022;130:105932.
PubMed Abstract available

WARNER L, O'Hara JT, Lin DJ, Oozeer N, et al
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
Oral Oncol. 2022;130:105909.
PubMed Abstract available

VARGHESE BT, Shivanesan P
Anatomical distortion of the right recurrent laryngeal nerve in level 7 neck dissection.
Oral Oncol. 2022;130:105929.
PubMed

SMILINE GIRIJA AS
Natural "epidrugs" and the need of basket trials in the treatment of oral cancer in India.
Oral Oncol. 2022;130:105931.
PubMed

SHIAO JC, Holt D, Ladbury C, Gao D, et al
The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
Oral Oncol. 2022;130:105907.
PubMed Abstract available

LOW SK, Reed CT, Millo C, Turkbey EB, et al
Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.
Oral Oncol. 2022;130:105928.
PubMed

PARAMASIVAM A
Plasma circulating tumor DNA as a molecular marker for oral cancer.
Oral Oncol. 2022;130:105926.
PubMed

SELVARAJ J, Yasothkumar D, Vishnu Priya V, Raj AT, et al
Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma.
Oral Oncol. 2022;130:105922.
PubMed

YANG X, Song H, Ji T, Du G, et al
The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
Oral Oncol. 2022;130:105924.
PubMed Abstract available

FORNER D, Mok F, Verma N, Karam I, et al
Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
Oral Oncol. 2022;130:105903.
PubMed Abstract available

PAZHANI J, Jayaraman S, Veeraraghavan VP, Somasundaram DB, et al
Targeting cancer associated fibroblasts - A TGF-beta based immunotherapy for head and neck squamous cell carcinoma.
Oral Oncol. 2022;130:105899.
PubMed

JIANG Y, Yang S, Qi Y
Comment on: The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
Oral Oncol. 2022;130:105872.
PubMed

MADY LJ, Baddour K, Hodges JC, Magana LC, et al
Corrigendum to "The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm" [Oral Oncol. 126 (2022) 105766].
Oral Oncol. 2022 May 2:105882. doi: 10.1016/j.oraloncology.2022.105882.
PubMed

SWARTZ JE, Smits HJG, Philippens MEP, de Bree R, et al
Correlation and colocalization of HIF-1alpha and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
Oral Oncol. 2022;128:105862.
PubMed Abstract available

YEOM S, Jung EK, Lee DH, Lee JK, et al
Clinical features and recurrence factors of benign neoplasms of the tongue base.
Oral Oncol. 2022;128:105866.
PubMed Abstract available

COUTU B, Ryan E, Christensen D, Lawrence E, et al
Positive margins matter regardless of subsequent resection findings.
Oral Oncol. 2022;128:105850.
PubMed Abstract available

MULLER RG, Hamill CS, Vu B, Thuener J, et al
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
Oral Oncol. 2022;128:105861.
PubMed Abstract available

MOLNAR K, Hietanen S, Liisanantti J, Koivunen P, et al
Quality of life after free flap reconstruction for the cancer of the head and neck: Comparison between five-year survivors and non-survivors.
Oral Oncol. 2022;128:105855.
PubMed Abstract available

TRANCHITO E, Cabrera C, Terry M, Li S, et al
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database.
Oral Oncol. 2022;128:105829.
PubMed Abstract available

WEN X, Hu Y, Liu Y, Li Z, et al
Conservative treatment of head and neck lymphoma is not the only effective treatment: A retrospective analysis of 301 cases.
Oral Oncol. 2022;128:105828.
PubMed Abstract available

April 2022

GALLOGLY JA JR, Weber AK, Mazul AL, Brinkmeier JV, et al
Inferior outcomes associated with emergency department presentation for head and neck cancer surgery.
Oral Oncol. 2022;129:105894.
PubMed Abstract available

SHE L, Tian K, Han J, Zuo W, et al
Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effectiveness analysis.
Oral Oncol. 2022;129:105871.
PubMed Abstract available

KATO A, Matsuda Y, Morioka R, Okui T, et al
Discrepancy between subjective and objective postoperative oral dysfunction assessment after oral cancer treatment: A single-center cross-sectional study.
Oral Oncol. 2022;129:105879.
PubMed Abstract available

HAIST C, Poschinski Z, Bister A, Hoffmann MJ, et al
Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas.
Oral Oncol. 2022;129:105867.
PubMed Abstract available

SEKAR D, Panagal M, Manimaran D, Ahmad N, et al
miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer.
Oral Oncol. 2022;129:105873.
PubMed

LIU T, Ma L, Song L, Yan B, et al
CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
Oral Oncol. 2022;129:105858.
PubMed Abstract available

NERALLA M, Senthilnthan P, Kubendiran D, Nandan A, et al
Dry needle therapy for post operative shoulder dysfunction in oral cancer patients.
Oral Oncol. 2022;128:105865.
PubMed

PETRELLI F, Trevisan F, Ghidini A, Capriotti V, et al
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis.
Oral Oncol. 2022;128:105864.
PubMed

ZHOU S, Chan C, Rulach R, Dyab H, et al
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
Oral Oncol. 2022;128:105870.
PubMed Abstract available

YANG ZC, Nie ZQ, Chen QY, Du CC, et al
Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.
Oral Oncol. 2022;128:105851.
PubMed Abstract available

FENG G, Feng H, Qi Y, Wang T, et al
Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
Oral Oncol. 2022;128:105859.
PubMed Abstract available

CHEN Y, Zheng X, Lin J, Gao X, et al
A high homologous recombination deficiency score is associated with poor survival and a non-inflamed tumor microenvironment in head and neck squamous cell carcinoma patients.
Oral Oncol. 2022;128:105860.
PubMed Abstract available

TIAN K, Han J, Wang Z, Chen J, et al
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis.
Oral Oncol. 2022;128:105842.
PubMed Abstract available

BALACHANDER K, Roy A, Priyadharsini JV, Murugan S, et al
Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer.
Oral Oncol. 2022;128:105857.
PubMed

DE LA COUR CD, Munk C, Aalborg GL, Kjaer SK, et al
Base of tongue/tonsillar and laryngeal cancer in Denmark 1994-2018: Temporal trends in incidence according to education and age.
Oral Oncol. 2022;128:105832.
PubMed Abstract available

BANERJEE A, Misra SR, Roy B, Singh S, et al
Central oral histopathology registry (COHR) - A proposal promising hope for oral cancer and oral pathology research.
Oral Oncol. 2022;128:105856.
PubMed

SEKAR D, Murthykumar K, Ganapathy D
miR-206 and its mimics: A predictive biomarker and therapeutic molecule in the treatment of oral cancer.
Oral Oncol. 2022;128:105849.
PubMed

RISCHIN D, Harrington KJ, Greil R, Soulieres D, et al
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Oral Oncol. 2022;128:105815.
PubMed Abstract available

VAIDYA K, Sarode SC, Gadre P, Gadre K, et al
Mammary analogue secretory carcinoma presenting as localized hematoma of the palate.
Oral Oncol. 2022;127:105821.
PubMed

BIJAI LK, Muthukrishnan A
Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
Oral Oncol. 2022;127:105810.
PubMed Abstract available

NAMRATA D, Lakshmi T, Rushabh D, Ezhilarasan D, et al
Role of stress management in oral malignant and premalignant conditions.
Oral Oncol. 2022;127:105813.
PubMed

DE SOUZA GP, Santos MM, Ferreira IN, Cunha JLS, et al
Oral basaloid squamous cell carcinoma: A case report with emphasis on histopathological diagnosis criteria.
Oral Oncol. 2022;127:105814.
PubMed Abstract available

SEKAR D
Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC).
Oral Oncol. 2022;127:105812.
PubMed

TANS L, Al-Mamgani A, Kwa SLS, Elbers JBW, et al
Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile.
Oral Oncol. 2022;127:105782.
PubMed Abstract available

BRINKMAN D, Callanan D, Jawad H, O'Sullivan R, et al
Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
Oral Oncol. 2022;127:105797.
PubMed Abstract available

ROH JL
Gland-preserving surgery of benign parotid tumours via postauricular sulcus incision: Is it safe and effective with the scarless incision?
Oral Oncol. 2022;127:105808.
PubMed Abstract available

WANG SJ, Shen SY, Lin B, Wang F, et al
Factors affecting postoperative sleep quality of patients undergoing flap transfer for head and neck reconstruction.
Oral Oncol. 2022;127:105804.
PubMed Abstract available

SARODE SC, Sarode GS, Sharma NK
Salivary gland carcinomas and molecular chaos: Additional perspectives.
Oral Oncol. 2022;127:105802.
PubMed

SEKAR D
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD).
Oral Oncol. 2022;127:105786.
PubMed

LIN A, Helgeson ES, Treister NS, Schmidt BL, et al
The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
Oral Oncol. 2022;127:105783.
PubMed Abstract available

COMER JC, King RB, Harris AB, Hitchcock KE, et al
Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
Oral Oncol. 2022;127:105767.
PubMed Abstract available

YANG Q, Cheng C, Zhu R, Guo F, et al
A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
Oral Oncol. 2022;127:105771.
PubMed Abstract available

EGAL ESA, Scarini JF, de Lima-Souza RA, Lavareze L, et al
Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
Oral Oncol. 2022;127:105777.
PubMed Abstract available

DODDAWAD VG, Premalatha BR, Sreeshyla HS, Nitin P, et al
Classification staging systems on clinical and radiographic features of inverted sinonasal papilloma: A case report.
Oral Oncol. 2022;127:105768.
PubMed Abstract available

March 2022

PATIL V, Noronha V, Joshi A, Menon N, et al
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
Oral Oncol. 2022;128:105816.
PubMed Abstract available

CHANG CT, Liu SP, Muo CH, Liao YF, et al
The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: A population-based cohort study.
Oral Oncol. 2022;128:105827.
PubMed Abstract available

HSIEH MC, Wang CC, Yang CC, Lien CF, et al
The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched study.
Oral Oncol. 2022;128:105848.
PubMed Abstract available

YANG X, Xu X, Zhang C, Ji T, et al
The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
Oral Oncol. 2022;128:105846.
PubMed Abstract available

RANJAN MISRA S, Das R
Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!
Oral Oncol. 2022;128:105845.
PubMed

MATTOX AK, D'Souza G, Khan Z, Allen H, et al
Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
Oral Oncol. 2022;128:105805.
PubMed Abstract available

BALACHANDER K, Paramasivam A
Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer.
Oral Oncol. 2022;127:105825.
PubMed

YAMAGUMA Y, Kaneuji T, Shirouzu S, Fukui T, et al
Combination therapy of Mohs paste and chemotherapy improved metastatic oral cancer to the precordium skin and bilateral axillary lymph nodes: A case report.
Oral Oncol. 2022;127:105817.
PubMed Abstract available

VILLARD A, Breuskin I, Casiraghi O, Asmandar S, et al
Confocal laser endomicroscopy and confocal microscopy for head and neck cancer imaging: Recent updates and future perspectives.
Oral Oncol. 2022;127:105826.
PubMed Abstract available

PATIL V, Alone M, Rai R, Noronha V, et al
Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers.
Oral Oncol. 2022;127:105824.
PubMed

DE LUCA P, Di Stadio A, Tassone D, de Campora L, et al
Large cervical mass and head and neck cancer. First report of ectopic papillary adenoma of the lung.
Oral Oncol. 2022;127:105823.
PubMed Abstract available

DEVARAJA K, Kabekkodu SP
Oral microbiome; a potential game-changer in the management of oral cancer?
Oral Oncol. 2022;127:105822.
PubMed

BONETTI VALENTE V, Mantovan Mazzon B, Urbano Collado F, Conrado Neto S, et al
Clinicopathological and prognostic profile of non-smoking and non-drinking head and neck cancer patients: a population-based comparative study.
Oral Oncol. 2022;127:105799.
PubMed Abstract available

SHETH S, Gilbert J, Deal AM, Chera B, et al
Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma.
Oral Oncol. 2022;127:105807.
PubMed

VALERO C, Yuan A, Zanoni DK, Lei E, et al
Young non-smokers with oral cancer: What are we missing and why?
Oral Oncol. 2022;127:105803.
PubMed Abstract available

ELUMALAI P, Ezhilarasan D, Lakshmi T
Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach.
Oral Oncol. 2022;127:105801.
PubMed

GLAZAR DJ, Johnson M, Farinhas J, Steuer CE, et al
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
Oral Oncol. 2022;127:105787.
PubMed Abstract available

ROUTILA J, Qiao X, Weltner J, Rantala JK, et al
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
Oral Oncol. 2022;127:105772.
PubMed Abstract available

BRODY RM, Shimunov D, Cohen RB, Lin A, et al
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
Oral Oncol. 2022;127:105798.
PubMed Abstract available

GONCALVES JM, Scarini JF, Gondak R, Altemani A, et al
Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
Oral Oncol. 2022;126:105779.
PubMed Abstract available

I GHANEM A, Woody NM, Schymick MA, Joshi NP, et al
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
Oral Oncol. 2022;126:105781.
PubMed Abstract available

LOMBARDI D, Tomasoni M, Lorini L, Gurizzan C, et al
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
Oral Oncol. 2022;126:105764.
PubMed Abstract available

CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations.
Oral Oncol. 2022;126:105751.
PubMed

AL-LAMI A, Gao C, Saddiq M, Al Zuhir N, et al
Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary.
Oral Oncol. 2022;126:105748.
PubMed Abstract available

SEKAR D
Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
Oral Oncol. 2022;126:105763.
PubMed

SILVA LC, Faustino ISP, Cantadori GR, Santos-Silva AR, et al
Adenocarcinoma not otherwise specified (NOS) arising in the sublingual gland: Rare case report and follow-up.
Oral Oncol. 2022;126:105754.
PubMed Abstract available

KANG CJ, Wen YW, Lee SR, Ng SH, et al
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
Oral Oncol. 2022;126:105750.
PubMed Abstract available

SAKTHIVEL P, Raveendran S, Rajeshwari M
Sinonasal small round blue cell tumors: What the clinician must know!
Oral Oncol. 2022;126:105735.
PubMed

YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
Clinical trial outcomes in oral squamous cell carcinoma: A pragmatic ideation.
Oral Oncol. 2022;126:105752.
PubMed

CHAGAS-NETO JL, Nogueira DPS, Santos-Neto AGD, Duarte IX, et al
Hyalinizing clear cell carcinoma of minor salivary glands: A case report with uncommon presentation.
Oral Oncol. 2022;126:105753.
PubMed Abstract available

E C, M D, K C, V A, et al
Trismus therapy devices: A systematic review.
Oral Oncol. 2022;126:105728.
PubMed Abstract available

NAYYAR V, Bhutia O, Kakkar A, Mishra D, et al
Primary intraosseous oncocytic mucoepidermoid carcinoma of the jaw: First case report.
Oral Oncol. 2022;126:105732.
PubMed

RAMOS-GARCIA P, Gonzalez-Moles MA, Warnakulasuriya S
Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
Oral Oncol. 2022;126:105734.
PubMed Abstract available

February 2022

QURESHI HA, Zhu X, Yang GH, Steadele M, et al
Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
Oral Oncol. 2022;127:105774.
PubMed Abstract available

BELGIOIA L, Becherini C, Bacigalupo A, Bonomo P, et al
Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
Oral Oncol. 2022;127:105773.
PubMed Abstract available

DAGLINAMRATA, Lakshmi T, Rushabh D, Dineshkumar T, et al
Telescreening as an alternate modality for early detection of oral cancer.
Oral Oncol. 2022;127:105785.
PubMed

HARING CT, Dermody SM, Yalamanchi P, Kang SY, et al
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
Oral Oncol. 2022;126:105776.
PubMed Abstract available

MICHMERHUIZEN NL, Heenan C, Wang J, Leonard E, et al
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model.
Oral Oncol. 2022;126:105770.
PubMed

MADY LJ, Baddour K, Hodges JC, Magana LC, et al
The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm.
Oral Oncol. 2022;126:105766.
PubMed Abstract available

ZHANG S, Zhang W, Zhang J
Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
Oral Oncol. 2022;126:105755.
PubMed Abstract available

LI JL, Hsieh TL, Ou MC, Lin FC, et al
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients.
Oral Oncol. 2022;126:105729.
PubMed

LENOCI D, Carenzo A, Cavalieri S, Pistore F, et al
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
Oral Oncol. 2022;126:105756.
PubMed

CHAN SK, Lin C, Huang SH, Chau TC, et al
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Oral Oncol. 2022;126:105736.
PubMed Abstract available

VAN MUNSTER MH, de Bree R, Breimer GE, Van Cann EM, et al
Surgical margins in the resection of oral squamous cell carcinoma under local versus general anesthesia.
Oral Oncol. 2022;125:105724.
PubMed Abstract available

KRISHNA A, Singh S, Kumar V
Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
Oral Oncol. 2022;125:105720.
PubMed

SILVERMAN DA, Parikh AS, Liu K, Zhan KY, et al
Predictors of survival following carotid blowout syndrome.
Oral Oncol. 2022;125:105723.
PubMed Abstract available

ZOTTI F, Nocini R, Capocasale G, Fior A, et al
Response to a Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence".
Oral Oncol. 2022;125:105714.
PubMed

TEZ M
Chronic mechanical irritation and oral squamous cell carcinoma: Let's look from evolutionary perspective.
Oral Oncol. 2022;125:105727.
PubMed

GANAPATHY D, Ramadoss R, Yuwanati M, Karthikeyan M, et al
Rarity of mucormycosis in oral squamous cell carcinoma: A clinical paradox?
Oral Oncol. 2022;125:105725.
PubMed

CHIN O, Alshafai L, O'Sullivan B, Su J, et al
Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.
Oral Oncol. 2022;125:105716.
PubMed Abstract available

FAUSTINO ISP, Georgaki M, Santos-Silva AR, Vargas PA, et al
Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis.
Oral Oncol. 2022;125:105710.
PubMed Abstract available

MENDEZ AI, Wihlidal JGJ, Eurich DT, Nichols AC, et al
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.
Oral Oncol. 2022;125:105701.
PubMed Abstract available

SARODE G, Sarode SC, Sharma NK
Phenotypic reflection of white sponge nevus in histomorphological features of oral squamous cell carcinoma.
Oral Oncol. 2022;125:105707.
PubMed

MISRA SR, Mishra N, Satpathy SK
Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?
Oral Oncol. 2022;125:105706.
PubMed

VAN WEERT S, Valstar M, Lissenberg-Witte B, Bloemena E, et al
Prognostic factors in acinic cell carcinoma of the head and neck: The Amsterdam experience.
Oral Oncol. 2022;125:105698.
PubMed Abstract available

CHEN TC, Wang C, Su LY, Lin MC, et al
Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma.
Oral Oncol. 2022;125:105683.
PubMed Abstract available

SAWHNEY S, Thiagarajan S, Balaji A, Sathe P, et al
Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.
Oral Oncol. 2022;125:105684.
PubMed Abstract available

FERREIRA PS, Rocha L, Bezerra APC, Nico MMS, et al
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
Oral Oncol. 2022;125:105674.
PubMed Abstract available

January 2022

SENGUPTA N, Sarode SC, Sarode GS, Ghone U, et al
Scarcity of publicly available oral cancer image datasets for machine learning research.
Oral Oncol. 2022;126:105737.
PubMed Abstract available

JONAS H, Simnica D, Bussmann L, Zech H, et al
Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN.
Oral Oncol. 2022;126:105733.
PubMed

SEKAR D
Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer.
Oral Oncol. 2022;126:105747.
PubMed

FERRAZZO KL
Regarding: "Clinical practice guidelines for dental management prior to radiation for head and neck cancer".
Oral Oncol. 2022;126:105731.
PubMed

WARD MC, Miller JA, Walker GV, Moeller BJ, et al
The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: A simulation.
Oral Oncol. 2022;126:105721.
PubMed Abstract available

LIU X, Li WF, Ding C, Chen L, et al
Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma - Pooled analysis of two randomized trials.
Oral Oncol. 2022;125:105718.
PubMed Abstract available

K AP, Selvakumar SC, Selvaraj J, Mony U, et al
Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics.
Oral Oncol. 2022;125:105713.
PubMed

ECONOMOPOULOU P, Kotsantis I, Psyrri A
Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success?
Oral Oncol. 2022 Jan 13:105717. doi: 10.1016/j.oraloncology.2022.105717.
PubMed

CARDIN GB, Bernard M, Bourbonnais J, Bahig H, et al
The rs6942067 genotype is associated with a worse overall survival in young or non-smoking HPV-negative patients with positive nodal status in head and neck squamous cell carcinoma.
Oral Oncol. 2022;125:105696.
PubMed

GILLIGAN G, Piemonte E, Lazos J, Panico R, et al
Chronic wounds of traumatic origin and oral cancer arising de novo: A potential association?
Oral Oncol. 2022;125:105711.
PubMed

PATIL V, Ghandade N, Noronha V, Menon N, et al
Hypomagnesemia in patients with locally advanced head and neck cancer treated weekly cisplatin-incidence and impact on outcomes.
Oral Oncol. 2022;125:105709.
PubMed

D'ASCANIO L, Latini G, Pandolfini M, Imperatori L, et al
Covid-19 negatively impacted on small oncology surgery but none on major procedures: Regional experience.
Oral Oncol. 2022;124:105439.
PubMed Abstract available

RAMDOSS R, Yuwanati M, Viola E A, Ramani P, et al
Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
Oral Oncol. 2022;124:105672.
PubMed

SARODE GS, Sarode SC, Yuwanati M, Gadbail A, et al
Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation.
Oral Oncol. 2022;124:105671.
PubMed

SANTANA T, Correia Neto IJ, Sugaya NN, Trierveiler M, et al
Myoepithelial carcinoma of the minor salivary glands: A case report of a rare tumor.
Oral Oncol. 2022;124:105667.
PubMed

VIITASALO S, Karhemo PR, Vaananen J, Ilmarinen T, et al
Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
Oral Oncol. 2022;124:105663.
PubMed Abstract available

PANTA P, Misra SR
Chronic mechanical irritation and oral squamous cell carcinoma: A case series.
Oral Oncol. 2022;124:105669.
PubMed

XAVIER-JUNIOR JCC, Ocanha-Xavier JP, Asato MA, Bernabe DG, et al
The 'AEIOU' system to identify primary oral melanoma.
Oral Oncol. 2022;124:105670.
PubMed Abstract available

SAKTHIVEL P, Thakar A, Fernandez-Fernandez MM, Panda S, et al
TransOral UltraSonic surgery (TOUSS) for oral cavity, oropharyngeal and supraglottic malignancy: A prospective study of feasibility, safety, margins, functional and survival outcomes.
Oral Oncol. 2022;124:105643.
PubMed Abstract available

KIM TH, Eun YG, Lee YC
A machine learning based survival prediction model for advanced parotid gland mucoepidermoid carcinoma.
Oral Oncol. 2022;124:105664.
PubMed

MISRA SR, Das R
Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation."
Oral Oncol. 2022;124:105661.
PubMed

DE FELICE F, Botticelli A
Cetuximab: Its role in patients unfit for cisplatin.
Oral Oncol. 2022;124:105654.
PubMed

ZANONI DK, Valero C, McGill MR, Montero PH, et al
Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?
Oral Oncol. 2022;124:105641.
PubMed Abstract available

ABBASI AI, Shetty SS, de Arruda JAA
Autotransplantation of teeth: An alternative for patients with malignant transformation of oral submucous fibrosis.
Oral Oncol. 2022;124:105644.
PubMed

LI MM, Mroz EA, Faquin WC, Lott-Limbach A, et al
ERalpha: A biomarker and treatment target for oropharyngeal cancer?
Oral Oncol. 2022;124:105637.
PubMed

RAMADOSS R, Yuwanati M, Ramani P, Krishnan R, et al
Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma.
Oral Oncol. 2022;124:105639.
PubMed

FAKHRAEI S, Layegh P, Darchini-Maragheh E, Tayyebi Meybodi N, et al
Oral verrucous carcinoma arising from pemphigus vulgaris: A rare coincidence.
Oral Oncol. 2022;124:105513.
PubMed

MALIK A, Panda S, Sakthivel P
Treatment of early glottic carcinoma: Is it a paradox of choices?
Oral Oncol. 2022;124:105516.
PubMed

PANDIAR D, Ramani P, Krishnan RP, Thamilselvan S, et al
Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: Recapitulation of embryonic plasticity?
Oral Oncol. 2022;124:105476.
PubMed

VARGHESE BT
Head and neck surgical oncology training in the current era of molecular oncology.
Oral Oncol. 2022;124:105474.
PubMed Abstract available

ZHANG L, Chen L, Xiao M, Xie X, et al
Locally advanced undifferentiated sarcomatoid carcinoma of the right maxillary sinus with PDCD6-TERT fusion: A rare case report.
Oral Oncol. 2022;124:105466.
PubMed Abstract available

December 2021

COHEN O, Brauer PR, Judson BL, Burtness BA, et al
Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
Oral Oncol. 2021;125:105694.
PubMed Abstract available

WANG J, Tian Y, Huang H, Huang D, et al
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Oral Oncol. 2021;125:105675.
PubMed Abstract available

SUBASH A, Bylapudi B, Thakur S, Rao VUS, et al
Oral cancer in India, a growing problem: Is limiting the exposure to avoidable risk factors the only way to reduce the disease burden?
Oral Oncol. 2021;125:105677.
PubMed Abstract available

MERCHANT YP, Mohan M, Shetty S, Bandemegal M, et al
The submandibular gland in neck dissection: A necessary casualty or a hapless victim?
Oral Oncol. 2021;125:105678.
PubMed

HERNDON P, Jassal JS, Cramer JD
Association between E-cigarette use and oral HPV-16 infection.
Oral Oncol. 2021;125:105676.
PubMed

DOU Y, Ma C, Wang K, Liu S, et al
Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes.
Oral Oncol. 2021;124:105657.
PubMed Abstract available

NOJI R, Kano Y, Hirai H, Onishi I, et al
MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.
Oral Oncol. 2021;124:105666.
PubMed Abstract available

WEI LY, Lin HC, Tsai FC, Ko JY, et al
Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival.
Oral Oncol. 2021;124:105665.
PubMed Abstract available

SARI SY, Yilmaz MT, Aktas BY, Aksoy S, et al
Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.
Oral Oncol. 2021;124:105658.
PubMed Abstract available

CRAMER JD, Grauer J
Modeling oral cancer screening in the United States population.
Oral Oncol. 2021;124:105656.
PubMed Abstract available

BIGELOW EO, Windon MJ, Fakhry C, Kiess AP, et al
Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.
Oral Oncol. 2021;123:105618.
PubMed Abstract available

CAI X, Zhang J, Han Y, Tang Q, et al
Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders.
Oral Oncol. 2021;123:105619.
PubMed Abstract available

ROMINE PE, Voutsinas J, Wu V, Tratt M, et al
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
Oral Oncol. 2021;123:105626.
PubMed Abstract available

BURNINGHAM K, Moore W, Moon D, Avkshtol V, et al
Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
Oral Oncol. 2021;123:105623.
PubMed Abstract available

GHONE U, Sarode GS, Sengupta N, Sarode SC, et al
Oral potentially malignant disorder and regular follow-up: Importance well understood with poor translation.
Oral Oncol. 2021;123:105630.
PubMed

MISHRA S, Thakur S, Rao VUS, Subash A, et al
Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
Oral Oncol. 2021;123:105614.
PubMed

BYLAPUDI B, Rao VUS, Subash A, Thakur S, et al
Does SLNB substitute END in the future with the sole advantage of preventing shoulder morbidity?
Oral Oncol. 2021;123:105628.
PubMed Abstract available

BERGER J, Zech HB, Hoffer K, von Bargen CM, et al
Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors.
Oral Oncol. 2021;123:105603.
PubMed Abstract available

NOEL CW, Forner D, Chepeha DB, Baran E, et al
The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
Oral Oncol. 2021;123:105595.
PubMed Abstract available

CHENG NM, Kang CJ, Tsai CY, Lee LY, et al
Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
Oral Oncol. 2021;123:105593.
PubMed Abstract available

MIMICA X, Yuan A, Hay A, Katabi N, et al
Mucoepidermoid carcinoma: Evaluating the prognostic impact of primary tumor site.
Oral Oncol. 2021;123:105602.
PubMed Abstract available

SIVANANDAN N, Nagarajan M, Roy A, Subramaniam A, et al
Invasive oral squamous cell carcinoma of maxillary alveolus in a Nicobari tribal woman after 17 years of tobacco cessation - A case report.
Oral Oncol. 2021;123:105601.
PubMed

PANTA P
Oral squamous cell carcinoma due to chronic mechanical irritation.
Oral Oncol. 2021;123:105616.
PubMed

VAN DER WAAL I
The term 'Proliferative verrucous leukoplakia' should be abandoned and this is why.
Oral Oncol. 2021;123:105621.
PubMed

FUSSEY J, Tomasoni M, Tirelli G, Giordano L, et al
Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience.
Oral Oncol. 2021;123:105577.
PubMed Abstract available

VARGHESE BT
Rearterialized islanded facial artery muco-muscular flap (iFAMM) flap in tongue reconstruction.
Oral Oncol. 2021;123:105592.
PubMed

LIU S, Bellile E, Nguyen A, Zarins K, et al
Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen.
Oral Oncol. 2021;123:105587.
PubMed Abstract available

JIMENEZ JE, Nilsen ML, Gooding WE, Anderson JL, et al
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity.
Oral Oncol. 2021;123:105574.
PubMed Abstract available

MERCHANT YP, Subash A, Rao VUS
Unravelling parotid metastasis in oral squamous cell carcinoma - Do they warrant inclusion in Staging?
Oral Oncol. 2021;123:105581.
PubMed

ARUN P, Arun I, Jain P, Manikantan K, et al
Determinants of prognosis in patients with oral squamous cell carcinoma metastasizing to a single cervical lymph node.
Oral Oncol. 2021;123:105586.
PubMed Abstract available

ASODA S, Miyashita H, Soma T, Munakata K, et al
Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue.
Oral Oncol. 2021;123:105629.
PubMed Abstract available

November 2021

GUPTA T, Maheshwari G, Kannan S, Nair S, et al
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for pract
Oral Oncol. 2021;124:105642.
PubMed Abstract available

CHAUHAN A, Kaur R, Ghoshal S, Chatterjee D, et al
Potential prognostic and predictive role of baseline circulating tumor cells in head and neck squamous cell carcinoma.
Oral Oncol. 2021;124:105636.
PubMed

FUEREDER T, Minichsdorfer C, Mittlboeck M, Wagner C, et al
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study.
Oral Oncol. 2021;124:105634.
PubMed Abstract available

DENARO N, Merlano M, Garrone O
In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
Oral Oncol. 2021;124:105640.
PubMed

THADURI A, Dungala D, Panuganti A, Majumdar KS, et al
Addressing the challenges of head and neck cancer care in India - A compelling need of the hour.
Oral Oncol. 2021;124:105638.
PubMed

MADHULAXMI M, Abhinav RP
Protein changes of WNT signaling pathway in oral cancer.
Oral Oncol. 2021;123:105624.
PubMed

KOWALCHUK RO, Van Abel KM, Yin LX, Garcia J, et al
Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.
Oral Oncol. 2021;123:105625.
PubMed Abstract available

GAU M, Fonseca A, Ozsahin M, Fayette J, et al
Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
Oral Oncol. 2021;123:105605.
PubMed Abstract available

MISHRA S, Subash A, Rao VUS, Thakur S, et al
Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy.
Oral Oncol. 2021;123:105594.
PubMed

GOLUSINSKI P, Corry J, Poorten VV, Simo R, et al
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
Oral Oncol. 2021;123:105620.
PubMed Abstract available

WATSON E, Dorna Mojdami Z, Oladega A, Hope A, et al
Clinical practice guidelines for dental management prior to radiation for head and neck cancer.
Oral Oncol. 2021;123:105604.
PubMed Abstract available

BRIL SI, Chargi N, Wendrich AW, Wegner I, et al
Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
Oral Oncol. 2021;123:105617.
PubMed Abstract available

WANG Y, Gao Y, Yuan L, Zhang J, et al
Psychological needs and associated factors among perioperative patients with oral cancer.
Oral Oncol. 2021;123:105615.
PubMed

JOY A, Rao VUS
Reply: Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
Oral Oncol. 2021;122:105535.
PubMed

SHAH A, Sumer BD, Schostag K, Balachandra S, et al
Institutional patterns of head and neck oncology care during the early phase of the COVID-19 pandemic: A retrospective, pooled cross-sectional analysis.
Oral Oncol. 2021;122:105564.
PubMed

LIAO CT, Yang LY, Lee LY, Lin CY, et al
Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
Oral Oncol. 2021;122:105547.
PubMed Abstract available

GRONLUND MP, Jakobsen KK, Mirian C, Gronhoj C, et al
Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014.
Oral Oncol. 2021;122:105583.
PubMed Abstract available

YU J, Tsay C, Sasaki C, Son YH, et al
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs.
Oral Oncol. 2021;122:105585.
PubMed Abstract available

SEE A, Chu C, Kiong KL, Teo C, et al
Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review.
Oral Oncol. 2021;122:105556.
PubMed

SAKTHIVEL P, Ramanikanth TV, Thakar A, Singh CA, et al
TransOral UltraSonic Surgery (TOUSS) assisted supraglottic laryngectomy: Expanding the spectrum of endoscopic head and neck surgeries.
Oral Oncol. 2021;122:105562.
PubMed

RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
Oral leukoplakia in adolescents: Report of a rare case and review of the literature.
Oral Oncol. 2021;122:105565.
PubMed Abstract available

THAKAR A, Sakthivel P, Sikka K
TransOral UltraSonic Surgery (TOUSS) and TransOral Laser (TOL) assisted supraglottic laryngectomy (TOUSS-TOL-SGL): Improvising techniques within the transoral corridor.
Oral Oncol. 2021;122:105573.
PubMed

LIU W, Zhu L, Xu L, Wu L, et al
Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology.
Oral Oncol. 2021;122:105571.
PubMed

LIN N, Gao J, Wang H, Zhang H, et al
Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral/oropharyngeal carcinoma.
Oral Oncol. 2021;122:105563.
PubMed Abstract available

RE M, Tomasetti M, Monaco F, Amati M, et al
NGS-based miRNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma.
Oral Oncol. 2021;122:105554.
PubMed Abstract available

MCDOWELL L, Casswell G, Bressel M, Drosdowsky A, et al
Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: An Australian cohort.
Oral Oncol. 2021;122:105560.
PubMed Abstract available

MIN PARK Y, Yol Lim J, Woo Koh Y, Kim SH, et al
Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment.
Oral Oncol. 2021;122:105559.
PubMed Abstract available

SANTANA T, Custodio M, Dayla Melo Oliveira C, Dos Santos Antunes E, et al
Parotid metastasis of clear cell renal cell carcinoma 8 years after nephrectomy.
Oral Oncol. 2021;122:105561.
PubMed

SHIKDAR S, Fowle E, Razaq H, Razaq W, et al
Hormonal receptor evaluation in salivary duct adenocarcinoma.
Oral Oncol. 2021;122:105548.
PubMed

FERRELI F, Festa BM, Costantino A, Malvezzi L, et al
Prevalence of occult level 2b nodal metastases in cN0 squamous cell carcinoma of the oral cavity: A systematic review and meta-analysis.
Oral Oncol. 2021;122:105540.
PubMed Abstract available

SINGH GK, Patil VM, Noronha V, Joshi A, et al
Weight loss and its impact on outcome in head and cancer patients during chemo-radiation.
Oral Oncol. 2021;122:105522.
PubMed Abstract available

VAN LE Q, Ngo DQ, Nguyen HX, Ngo QX, et al
Transoral robotic thyroidectomy: First case as a new technique in Vietnam.
Oral Oncol. 2021;122:105542.
PubMed

BULBUL MG, Tarabichi O, Parikh AS, Yoon BC, et al
The utility of intra-oral ultrasound in improving deep margin clearance of oral tongue cancer resections.
Oral Oncol. 2021;122:105512.
PubMed Abstract available

PATEL V, Galloway TJ, Liu JC
The impact of positive margin on survival in oral cavity squamous cell carcinoma.
Oral Oncol. 2021;122:105499.
PubMed Abstract available

October 2021

GEORGE A, Saseendran A, Joseph ST, Gopal KR, et al
Submandibular gland - The victim of neck dissection.
Oral Oncol. 2021;123:105591.
PubMed

CABEZAS-CAMARERO S, Alonso-Ovies A, Merino-Menendez S, Cabrera-Martin MN, et al
Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer.
Oral Oncol. 2021;123:105589.
PubMed Abstract available

BRUIJNEN CP, de Groot LGR, Vondeling AM, de Bree R, et al
Functional decline after surgery in older patients with head and neck cancer.
Oral Oncol. 2021;123:105584.
PubMed Abstract available

PUTHIYOTTIL IV, Subash A, Thakur S, Rao VUS, et al
Elective neck dissection versus sentinel node biopsy in early oral cavity cancer - Are we ready for transition?
Oral Oncol. 2021;123:105597.
PubMed

SHINN JR, Carey RM, Mady LJ, Shimunov D, et al
Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinoma.
Oral Oncol. 2021;123:105570.
PubMed Abstract available

JOSE MARTELLI A, Assis Machado R, Medeiros Pereira W, Balduino Guimaraes Santos F, et al
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2.
Oral Oncol. 2021;123:105600.
PubMed

YUWANATI M, Sarode SC, Gadbail A, Gondivkar S, et al
Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain.
Oral Oncol. 2021;123:105596.
PubMed

YU ST, Ge JN, Sun BH, Wei ZG, et al
Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
Oral Oncol. 2021;123:105567.
PubMed Abstract available

SHU L, Wang D, Nannapaneni S, Sun Y, et al
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
Oral Oncol. 2021;122:105546.
PubMed Abstract available

MA D, Orner D, Ghaly MM, Parashar B, et al
Automated health chats for symptom management of head and neck cancer patients undergoing radiation therapy.
Oral Oncol. 2021;122:105551.
PubMed Abstract available

SHISHODIA G, Toledo RRG, Rong X, Zimmerman E, et al
4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
Oral Oncol. 2021;122:105578.
PubMed Abstract available

ZHAO Y, Li WF, Li QJ, He SW, et al
WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma.
Oral Oncol. 2021;122:105576.
PubMed Abstract available

ROSENBERG AJ, Agrawal N, Pearson A, Gooi Z, et al
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
Oral Oncol. 2021;122:105566.
PubMed Abstract available

TSENG WH, Li TH, Chiu HL, Yang TL, et al
Long-term swallowing-related outcomes in oral cancer patients receiving proactive swallowing therapy.
Oral Oncol. 2021;122:105569.
PubMed Abstract available

BRIL SI, van Beers MA, Chargi N, Carrillo Minulina N, et al
Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer.
Oral Oncol. 2021;122:105558.
PubMed

PENG H, Chen L, Mao YP, Tian L, et al
Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma.
Oral Oncol. 2021;122:105555.
PubMed Abstract available

OZER NE, Ilhan B, Guneri P
Patient specific follow-up to monitor the risk of malignant transformation on oral mucosa.
Oral Oncol. 2021;121:105300.
PubMed

CARNEVALE C, Pagan-Pomar A, Bianchi A, Sarria-Echegaray P, et al
Right colonic interposition for severe pharyngoesophageal stricture in head and neck patients: A feasible rescue strategy after multiple failed reconstructive options.
Oral Oncol. 2021;121:105481.
PubMed Abstract available

HANS S, Chebib E, Chekkoury-Idrissi Y, Distinguin L, et al
Surgical and oncological outcomes of transoral robotic total laryngectomy: A case series.
Oral Oncol. 2021;121:105511.
PubMed Abstract available

MOFFA A, Giorgi L, Costantino A, De Benedetto L, et al
Accuracy of autofluorescence and chemiluminescence in the diagnosis of oral Dysplasia and Carcinoma: A systematic review and Meta-analysis.
Oral Oncol. 2021;121:105482.
PubMed Abstract available

LIU W, Yang X, Shen Z, Shi L, et al
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders.
Oral Oncol. 2021;121:105479.
PubMed

BOUCHER A, Ezzat S, Hotte S, Rachinsky I, et al
Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
Oral Oncol. 2021;121:105477.
PubMed Abstract available

CHEN HB, Gong XY, Li W, Chen DS, et al
Genomic landscape and tumor mutation burden analysis of Chinese patients with sarcomatoid carcinoma of the head and neck.
Oral Oncol. 2021;121:105436.
PubMed Abstract available

PARK JO, Lee DH, Kim MR, Kim SY, et al
Transoral endoscopic thyroidectomy using a self-retaining retractor as an alternative to carbon dioxide gas insufflation: A comparative analysis of 131 cases.
Oral Oncol. 2021;121:105463.
PubMed Abstract available

CHAMOLI A, Gosavi AS, Shirwadkar UP, Wangdale KV, et al
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics.
Oral Oncol. 2021;121:105451.
PubMed Abstract available

FINEGERSH A, Voora RS, Panuganti B, Faraji F, et al
Robotic surgery may improve overall survival for T1 and T2 tumors of the hypopharynx: An NCDB cohort study.
Oral Oncol. 2021;121:105440.
PubMed Abstract available

GILVETTI C, Soneji C, Bisase B, Barrett AW, et al
Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery uni
Oral Oncol. 2021;121:105462.
PubMed Abstract available

LI Y, Gong L, Qin N, Wei X, et al
Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma.
Oral Oncol. 2021;121:105437.
PubMed Abstract available

WU T, Liu Z, Yong X, Mei G, et al
P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
Oral Oncol. 2021;121:105399.
PubMed Abstract available

AL MASALMEH N, Kukreja G, Zaiem F, Raza SN, et al
p16 positive oropharyngeal small cell cancer: A case report.
Oral Oncol. 2021;121:105391.
PubMed Abstract available

PANDIAR D, Ramani P, Krishnan RP, Monica K, et al
Multifaceted multinucleated giant cells in oral squamous cell carcinoma.
Oral Oncol. 2021;121:105400.
PubMed

HARING CT, Brummel C, Bhambhani C, Jewell B, et al
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation.
Oral Oncol. 2021;121:105332.
PubMed

September 2021

CURY SS, Miranda PM, Marchi FA, Canto LMD, et al
Germline variants in DNA repair genes are associated with young-onset head and neck cancer.
Oral Oncol. 2021;122:105545.
PubMed Abstract available

WANG BC
Adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Finding the suitable population.
Oral Oncol. 2021 Sep 28:105544. doi: 10.1016/j.oraloncology.2021.105544.
PubMed

SARODE SC, Sarode GS, Sengupta N, Ghone U, et al
Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer.
Oral Oncol. 2021;122:105525.
PubMed

TJOA T, Rathi VK, Goyal N, Yarlagadda BB, et al
Pneumonia, urinary tract infection, bacteremia, and Clostridioides difficile infection following major head and neck free and pedicled flap surgeries.
Oral Oncol. 2021;122:105541.
PubMed Abstract available

MENON N, Patil V, Noronha V, Joshi A, et al
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
Oral Oncol. 2021;122:105517.
PubMed Abstract available

ZHU MY, Sun XS, Guo SS, Chen QY, et al
Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?
Oral Oncol. 2021;122:105539.
PubMed Abstract available

ZHOU X, Xu T, Yang Y, Xing X, et al
Survival impact of increasing time to IMRT initiation following induction chemotherapy in nasopharyngeal carcinoma: A propensity score-matched analysis.
Oral Oncol. 2021;122:105506.
PubMed Abstract available

KIONG KL, Bell D, Yao CM, Ferrarotto R, et al
Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Oral Oncol. 2021;122:105520.
PubMed Abstract available

AJAZ S, Muneer R, Siddiqa A, Ali Memon M, et al
Association of specific single nucleotide variants (SNVs) in the promoter and 3'-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and higher tumour grade of head and neck cancers.
Oral Oncol. 2021;122:105519.
PubMed Abstract available

TSAI TY, Chou YC, Lu YA, Kang CJ, et al
The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
Oral Oncol. 2021;122:105518.
PubMed Abstract available

IDA S, Takahashi H, Kawabata-Iwakawa R, Mito I, et al
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
Oral Oncol. 2021;122:105508.
PubMed Abstract available

SAKTHIVEL P, Malik A, Panda S, Dhiwakar M, et al
8 "S" of obturators in Head and Neck Cancer Rehabilitation during COVID-19 pandemic.
Oral Oncol. 2021 Sep 8:105523. doi: 10.1016/j.oraloncology.2021.105523.
PubMed

MILLIET F, Bozec A, Schiappa R, Viotti J, et al
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
Oral Oncol. 2021;122:105503.
PubMed Abstract available

VAN HINTE G, Sancak T, Weijs WLJ, Merkx MAW, et al
Effect of elective neck dissection versus sentinel lymph node biopsy on shoulder morbidity and health-related quality of life in patients with oral cavity cancer: A longitudinal comparative cohort study.
Oral Oncol. 2021;122:105510.
PubMed Abstract available

D'SOUZA ZI, Desai RS, Shirsat PM, Bansal S, et al
Comment on "Suture line recurrence and oral squamous cell carcinoma: A viewpoint" by Sarode et al (October 2020).
Oral Oncol. 2021;120:105297.
PubMed

CHIDAMBARANATHAN N, Thiagarajan S
Is it time to look beyond just the depth of invasion to decide the management of neck in early oral squamous cell carcinoma?
Oral Oncol. 2021;120:105291.
PubMed

MEROLLA F, Ilardi G, Di Spigna G, Russo D, et al
Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.
Oral Oncol. 2021;120:105367.
PubMed Abstract available

HERREROS-POMARES A, Llorens C, Soriano B, Zhang F, et al
Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens.
Oral Oncol. 2021;120:105404.
PubMed Abstract available

LI Z, Zhang L, Liu FY, Li P, et al
MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
Oral Oncol. 2021;120:105401.
PubMed Abstract available

GUDI S, O'Sullivan B, Hosni A, Su J, et al
Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.
Oral Oncol. 2021;120:105419.
PubMed Abstract available

CHEN CM, Chu TH, Chou CC, Chien CY, et al
Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Oral Oncol. 2021;120:105402.
PubMed Abstract available

SHAH S, Mahajan A, Thiagarajan S, Chidambaranathan N, et al
Importance and implications of neurovascular bundle involvement and other MRI findings of oral tongue squamous cell carcinoma (OTSCC) on prognosis.
Oral Oncol. 2021;120:105403.
PubMed Abstract available

TAN LC, Yu PC, Wang J, Zhou XY, et al
BCOR-CCNB3 rearranged sarcoma arising in neck misdiagnosed as thyroid cancer: A case report.
Oral Oncol. 2021;120:105290.
PubMed Abstract available

FUJIMI A, Nagamachi Y, Yamauchi N, Nishisato T, et al
Eribulin in combination with HER2-targeted antibodies for successful treatment of metastatic salivary duct carcinoma: A report of two cases.
Oral Oncol. 2021;120:105287.
PubMed

DE LIMA-SOUZA RA, Scarini JF, Egal ESA, Crescencio LR, et al
Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: An immunohistochemical study.
Oral Oncol. 2021;120:105262.
PubMed Abstract available

August 2021

WRIGHT CM, Lee DY, Shimunov D, Carmona R, et al
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
Oral Oncol. 2021;121:105509.
PubMed Abstract available

VERDONCK-DE LEEUW IM, Melissant H, Lissenberg-Witte BI, Baatenburg de Jong RJ, et al
Associations between testosterone and patient reported sexual outcomes among male and female head and neck cancer patients before and six months after treatment: A pilot study.
Oral Oncol. 2021;121:105505.
PubMed Abstract available

SCHAIK JEV, Halmos GB, Witjes MJH, Plaat BEC, et al
An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging.
Oral Oncol. 2021;121:105504.
PubMed Abstract available

MYATRA SN, Gupta S, D'Cruz AK, Rajanala V, et al
Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: A prospective observational study in seven hundred and twenty patients.
Oral Oncol. 2021;121:105502.
PubMed Abstract available

MIN Y, Xiang K, Feng Y, Chen H, et al
Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma.
Oral Oncol. 2021;121:105507.
PubMed Abstract available

YANG Q, Xia L, Lin M, Zhang MX, et al
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial.
Oral Oncol. 2021;121:105494.
PubMed Abstract available

HOCHFELDER CG, Mehta V, Kabarriti R, McGinn AP, et al
Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
Oral Oncol. 2021;121:105470.
PubMed Abstract available

BUENO DE OLIVEIRA T, Camila Braun A, Ribaldo Nicolau U, Ali Abdallah E, et al
Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
Oral Oncol. 2021;121:105480.
PubMed Abstract available

NAGPAL P, Pruthi DS, Pandey M, Yadav A, et al
Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
Oral Oncol. 2021;121:105483.
PubMed Abstract available

JAWERT F, Nyman J, Olsson E, Adok C, et al
Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Oral Oncol. 2021;121:105469.
PubMed Abstract available

OHKOSHI A, Ishii R, Wakamori S, Nakayama Y, et al
Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study.
Oral Oncol. 2021;121:105475.
PubMed Abstract available

ENGEL MSD, van der Lans RJL, Jansen JC, Leemans CR, et al
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review.
Oral Oncol. 2021;121:105465.
PubMed Abstract available

SAKTHIVEL P, Subramanian P, Pulimala S, Panda S, et al
A call for the universal acceptance of the modified Milan system for reporting salivary gland cytopathology.
Oral Oncol. 2021;119:105255.
PubMed

MCDOWELL L, Corry J
Regarding "Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey" - Intra- and inter-specialty variability and the underutilisation o
Oral Oncol. 2021;119:105248.
PubMed

TRETIAKOW D, Przewozny T, Skorek A, Mikaszewski B, et al
Regarding to "Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?"
Oral Oncol. 2021;119:105227.
PubMed

KANG CJ, Tsai CY, Lee LY, Lin CY, et al
Prognostic stratification of patients with AJCC 2018 pStage IVB oral cavity cancer: Should pT4b and pN3 disease be reclassified?
Oral Oncol. 2021;119:105371.
PubMed Abstract available

PANG Y, Sun L, Liu H, Ma J, et al
Differential diagnosis and treatment of salivary secretory carcinoma and acinic cell carcinoma.
Oral Oncol. 2021;119:105370.
PubMed Abstract available

HARRIS JA, Hunter WP, Ji YD, Hanna GJ, et al
Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival.
Oral Oncol. 2021;119:105364.
PubMed Abstract available

FARAH CS, Fox S, Shearston K, Newman L, et al
Lichenoid dysplasia is not a distinct pathological entity.
Oral Oncol. 2021;119:105362.
PubMed Abstract available

CHOI N, Kim Z, Song BH, Park W, et al
Prediction of risk factors for pharyngo-cutaneous fistula after total laryngectomy using artificial intelligence.
Oral Oncol. 2021;119:105357.
PubMed Abstract available

SUBRAMANIAM N, Palme CE, Low TH
Combined approach for malignant tumours of the deep lobe of the parotid involving the stylomandibular tunnel and parapharyngeal space.
Oral Oncol. 2021;119:105283.
PubMed

MARANZANO M, D'Ascanio L, Ricci G, Omer H, et al
Misinterpretation of head and neck masses can delay the correct diagnosis. A two-step demolitive-reconstruction surgery for saving patient's life.
Oral Oncol. 2021;119:105197.
PubMed Abstract available

FIACCHINI G, Benettini G, Trico D, Torregrossa L, et al
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis.
Oral Oncol. 2021;119:105252.
PubMed Abstract available

SINGH N, Das S, Mehta S
Oral tumour causing airway obstruction with stridor: Situation guided team management.
Oral Oncol. 2021;119:105247.
PubMed

MUNNANGI A, Kadapathri A, Pillai V, Shetty V, et al
Should radiological staging of advanced buccal mucosa cancer preclude curative intent treatment? A prospective evaluation.
Oral Oncol. 2021;119:105246.
PubMed

July 2021

MAO L, Xiao Y, Yang QC, Yang SC, et al
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
Oral Oncol. 2021;121:105472.
PubMed Abstract available

NIEUWENHUIS ER, Kolenaar B, van Bemmel AJM, Hof JJ, et al
A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study.
Oral Oncol. 2021;121:105464.
PubMed Abstract available

MATSUDA Y, Okui T, Karino M, Aoi N, et al
Postoperative oral dysfunction following oral cancer resection and reconstruction: A preliminary cross-sectional study.
Oral Oncol. 2021;121:105468.
PubMed Abstract available

NAUTA IH, Klausch T, van de Ven PM, Hoebers FJP, et al
The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis.
Oral Oncol. 2021;121:105454.
PubMed Abstract available

DRAKE V, Bigelow E, Fakhry C, Windon M, et al
Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
Oral Oncol. 2021;121:105461.
PubMed Abstract available

KIM C, Martinez E, Kulich M, Swanson MS, et al
Surgeon practice patterns in transoral robotic surgery for HPV-related oropharyngeal cancer.
Oral Oncol. 2021;121:105460.
PubMed Abstract available

XU Y, Chen M, Guo Q, Peng H, et al
Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
Oral Oncol. 2021;121:105435.
PubMed Abstract available

ALMANGUSH A, Alabi RO, Makitie AA, Leivo I, et al
Machine learning in head and neck cancer: Importance of a web-based prognostic tool for improved decision making.
Oral Oncol. 2021 Jul 12:105452. doi: 10.1016/j.oraloncology.2021.105452.
PubMed

KOUKETSU A, Miyashita H, Kojima I, Sakamoto M, et al
Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
Oral Oncol. 2021;120:105453.
PubMed Abstract available

MERCHANT YP, Kudpaje A, Rao VUS
Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!
Oral Oncol. 2021 Jul 11:105441. doi: 10.1016/j.oraloncology.2021.105441.
PubMed

IQBAL MS, Kovarik J, Patil R, Kelly CG, et al
Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer?
Oral Oncol. 2021 Jul 9:105455. doi: 10.1016/j.oraloncology.2021.105455.
PubMed

IMADUDDIN M, Sultania M, Vigneshwaran B, Muduly DK, et al
Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help.
Oral Oncol. 2021 Jul 5:105438. doi: 10.1016/j.oraloncology.2021.105438.
PubMed

WILKIE MD, Lancaster J, Roland NJ, Jones TM, et al
Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives.
Oral Oncol. 2021;120:105432.
PubMed Abstract available

KIM SY, Beer M, Tshering Vogel DW
Imaging in head and neck cancers: Update for non-radiologist.
Oral Oncol. 2021;120:105434.
PubMed Abstract available

FARLOW JL, Brenner JC, Lei YL, Chinn SB, et al
Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
Oral Oncol. 2021;120:105420.
PubMed Abstract available

STABENAU KA, Akakpo KE, Richmon JD, McMullen C, et al
Postoperative wound infections in head and neck surgery: The current state of antiseptic and antibiotic practices.
Oral Oncol. 2021;118:105361.
PubMed

DA COSTA REAR, da Silva Junior RG, Magalhaes LAN, Mendes JR, et al
Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report.
Oral Oncol. 2021;118:105373.
PubMed Abstract available

SHARMA D, Rimal J, Kumar Maharjan I, Shrestha A, et al
Evaluation of oral potentially malignant disorders with autoflorescence, reflectance spectroscopy and vital staining and their correlation with histopathology - Hospital based prospective study.
Oral Oncol. 2021;118:105312.
PubMed Abstract available

PANTA P, Dhopathi SR, Gilligan G, Seshadri M, et al
Invasive oral squamous cell carcinoma induced by concurrent smokeless tobacco and creamy snuff use: A case report.
Oral Oncol. 2021;118:105354.
PubMed Abstract available

TSAI CY, Lee SR, Lee LY, Hsueh C, et al
Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum.
Oral Oncol. 2021;118:105334.
PubMed Abstract available

BARRETT TF, Mazul AL, Stepan KO, Wood CB, et al
The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database.
Oral Oncol. 2021;118:105330.
PubMed Abstract available

DE LIMA-SOUZA RA, Leonel ACLDS, de Almeida OP, de Castro JFL, et al
Salivary gland cystadenocarcinoma: Rare neoplasm in buccal mucosa.
Oral Oncol. 2021;118:105314.
PubMed Abstract available

DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
Oral field cancerization: A critical appraisal.
Oral Oncol. 2021;118:105304.
PubMed

JAKHETIYA A, Kaul P, Pandey A, Patel T, et al
Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma.
Oral Oncol. 2021;118:105316.
PubMed Abstract available

TURNER MT, Stokes WA, Stokes CM, Hassid S, et al
Airway and bleeding complications of transoral robotic supraglottic laryngectomy (TORS-SGL): A systematic review and meta-analysis.
Oral Oncol. 2021;118:105301.
PubMed

MCDOWELL L, Gough K, King M, Corry J, et al
Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer - A review of the literature and PRO methodology.
Oral Oncol. 2021;118:105309.
PubMed Abstract available

DHEERAJ K, Kumar R, Pinnaka LB
6 "I" for endoscopic surgical management of early glottic squamous cell carcinomas.
Oral Oncol. 2021;118:105308.
PubMed

June 2021

PATEL KB, Mroz EA, Faquin WC, Rocco JW, et al
A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
Oral Oncol. 2021;120:105421.
PubMed Abstract available

RIBEIRO IP, Lopes T, Pedro N, Barroso L, et al
Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?
Oral Oncol. 2021 Jun 26:105418. doi: 10.1016/j.oraloncology.2021.105418.
PubMed

DAHLSTROM KR, Anderson KS, Guo M, Kwon MC, et al
Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
Oral Oncol. 2021;120:105397.
PubMed Abstract available

YANG J, Wan SQ, Huang L, Zhong WJ, et al
Analysis of hospitalization costs and length of stay for oral cancer patients undergoing surgery: Evidence from Hunan, China.
Oral Oncol. 2021;119:105363.
PubMed Abstract available

AMBRE S, Sultania M, Biswal S, Mitra S, et al
Poorly differentiated "insular" thyroid carcinoma with solitary vascular mandibular metastasis - A rare histology and management.
Oral Oncol. 2021 Jun 24:105416. doi: 10.1016/j.oraloncology.2021.105416.
PubMed

ZHU MY, Wu HJ, Miao JJ, Di MP, et al
Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
Oral Oncol. 2021;120:105378.
PubMed Abstract available

LENZE NR, Farquhar DR, Sheth S, Zevallos JP, et al
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.
Oral Oncol. 2021;119:105377.
PubMed Abstract available

LIEN MY, Wang TH, Hsieh CY, Tsai MH, et al
Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival.
Oral Oncol. 2021;119:105380.
PubMed Abstract available

KAVARTHAPU A, Gurumoorthy K
Linking chronic periodontitis and oral cancer: A review.
Oral Oncol. 2021 Jun 14:105375. doi: 10.1016/j.oraloncology.2021.105375.
PubMed Abstract available

MA C, Sheng S, Shen Y, Gao W, et al
A comparative study on using superior thyroid artery perforator flaps versus traditional sternocleidomastoid myocutaneous flaps for reconstructions after oral cancer ablation: "New tricks for old dogs"?
Oral Oncol. 2021 Jun 11:105374. doi: 10.1016/j.oraloncology.2021.105374.
PubMed Abstract available

BRAS L, de Vries J, Festen S, Steenbakkers RJHM, et al
Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study.
Oral Oncol. 2021;118:105329.
PubMed Abstract available

KARABAJAKIAN A, Bouaoud J, Michon L, Kamal M, et al
Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity.
Oral Oncol. 2021;119:105368.
PubMed Abstract available

XU J, Wang R, Wang T, Wang T, et al
Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
Oral Oncol. 2021;119:105369.
PubMed Abstract available

ALVES LDB, de Melo AC, de Lima Araujo LH, Thiago LS, et al
Secretory carcinoma of salivary glands at the National Cancer Institute: A 20-year retrospective clinical, pathological, immunohistochemical and molecular study.
Oral Oncol. 2021;117:105198.
PubMed Abstract available

VARGHESE BT, Divya GM, Janardhan D, Thomas S, et al
Is there a role for HRCT in head and neck surgical oncology work up during the COVID pandemic?
Oral Oncol. 2021;117:105194.
PubMed

JIANG WN, Olson R
Transoral surgery may be less cost effective than radiotherapy: In response to: Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-medicare analysis.
Oral Oncol. 2021;117:105178.
PubMed

PARIKH AS, Kang SY
Variation in elective treatment of the contralateral neck in oropharyngeal cancer.
Oral Oncol. 2021;117:105186.
PubMed

SARODE GS, Sarode SC, Sengupta N, Sharma NK, et al
Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
Oral Oncol. 2021;117:105181.
PubMed Abstract available

COMBES JD, Voisin N, Perie S, Malard O, et al
History of tonsillectomy and risk of oropharyngeal cancer.
Oral Oncol. 2021;117:105302.
PubMed Abstract available

PATEL MR, Ottenstein L, Ryan M, Farrell A, et al
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.
Oral Oncol. 2021;117:105294.
PubMed Abstract available

HEFT NEAL ME, Gensterblum-Miller E, Bhangale AD, Kulkarni A, et al
Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.
Oral Oncol. 2021;117:105270.
PubMed Abstract available

BURASSAKARN A, Srisathaporn S, Pientong C, Wongjampa W, et al
Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-alpha pathway.
Oral Oncol. 2021;117:105279.
PubMed Abstract available

May 2021

TECKIE S, Wotman M, Marziliano A, Orner D, et al
Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).
Oral Oncol. 2021;119:105328.
PubMed Abstract available

DE FELICE F, Lei M, Oakley R, Lyons A, et al
Risk stratified follow up for head and neck cancer patients - An evidence based proposal.
Oral Oncol. 2021;119:105365.
PubMed Abstract available

LIN MC, Leu YS, Chiang CJ, Ko JY, et al
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis.
Oral Oncol. 2021;119:105358.
PubMed Abstract available

PENG Y, Xiao L, Rong H, Ou Z, et al
Single-cell profiling of tumor-infiltrating TCF1/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer.
Oral Oncol. 2021;119:105348.
PubMed Abstract available

COSTANTINO A, De Virgilio A, Spriano G
Is the current oropharyngeal cancer T classification adequate in the era of HPV and transoral robotic surgery?
Oral Oncol. 2021 May 25:105359. doi: 10.1016/j.oraloncology.2021.105359.
PubMed

DESIDERI I, Becherini C, Belgioia L, Merlotti A, et al
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review.
Oral Oncol. 2021;119:105355.
PubMed Abstract available

BERZENJI D, Sewnaik A, Keereweer S, Monserez DA, et al
Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma.
Oral Oncol. 2021;119:105356.
PubMed Abstract available

SCHOONBEEK RC, Bult FFS, Plaat BEC, Witjes MJH, et al
Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival.
Oral Oncol. 2021;118:105350.
PubMed Abstract available

CHEN X, Li Y, Li X, Cao X, et al
An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
Oral Oncol. 2021;118:105335.
PubMed Abstract available

PATTERSON JM, Lu L, Watson LJ, Harding S, et al
Trends in, and predictors of, swallowing and social eating outcomes in head and neck cancer survivors: A longitudinal analysis of head and neck 5000.
Oral Oncol. 2021;118:105344.
PubMed Abstract available

AL-QURAYSHI Z, Randolph GW, Kandil E
Cost-effectiveness of computed tomography nodal scan in patients with papillary thyroid carcinoma.
Oral Oncol. 2021;118:105326.
PubMed Abstract available

VENTURA TMO, Santos PSS, Ribeiro NR, de Lima Leite A, et al
Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?
Oral Oncol. 2021 May 10:105315. doi: 10.1016/j.oraloncology.2021.105315.
PubMed Abstract available

ZHOU L
Concerns about human papillomavirus-associated oropharyngeal cancer detection methods.
Oral Oncol. 2021;116:105143.
PubMed

THADURI A, Bansal A, Anthony ML, Narayan ML, et al
Brown tumor, parathyroid adenoma, and papillary thyroid cancer: A triple whammy.
Oral Oncol. 2021;116:105159.
PubMed

DOUMAS S, Koursoumi R, Dhanda J, Surwald C, et al
Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?
Oral Oncol. 2021;116:105170.
PubMed

NGUYEN A, Nagasaka M
Forget me not - Incorporating standard chemotherapy in an exciting era of clinical trials.
Oral Oncol. 2021;116:105160.
PubMed Abstract available

RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia.
Oral Oncol. 2021;116:105144.
PubMed Abstract available

HAIST C, Schulte E, Bartels N, Bister A, et al
CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells.
Oral Oncol. 2021;116:105259.
PubMed Abstract available

DE KONING KJ, Koppes SA, de Bree R, Dankbaar JW, et al
Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - Comparison with conventional treatment.
Oral Oncol. 2021;116:105249.
PubMed Abstract available

SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
Oral potential malignant disorders - A long list not to be forgotten.
Oral Oncol. 2021;116:105244.
PubMed

HERREROS-POMARES A, Llorens C, Soriano B, Bagan L, et al
Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Oral Oncol. 2021;116:105191.
PubMed Abstract available

LI R, Wang Q, Yan L, Zhu Y, et al
Radiotherapy versus partial laryngectomy in the management of early glottic cancer with anterior commissure involvement: A propensity score matched study with 256 patients.
Oral Oncol. 2021;116:105230.
PubMed Abstract available

NEWMAN M, Dziegielewski PT, Nguyen NTA, Seikaly HS, et al
Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma.
Oral Oncol. 2021;116:105195.
PubMed Abstract available

OH LJ, Asher R, Veness M, Smee R, et al
Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional study.
Oral Oncol. 2021;116:105210.
PubMed Abstract available

BAREM RABENHORST SH, Lima Verde Osterne R, Weege Nonaka CF, Montezuma Sales Rodrigues A, et al
Detection of deletions in 1q25, 1p36 and 1pTEL and chromosome 17 aneuploidy in oral epithelial dysplasia and oral squamous cell carcinoma by fluorescence in situ hybridization (FISH).
Oral Oncol. 2021;116:105221.
PubMed Abstract available

April 2021

DA SILVA LEONEL ACL, Ribeiro ILA, de Souza MLM, Kaminagakura E, et al
COVID-19, changes in smoking behaviour, and head and neck cancer: Current data and future perspectives.
Oral Oncol. 2021 Apr 30:105327. doi: 10.1016/j.oraloncology.2021.105327.
PubMed

ZONG J, Liu Y, Liang Q, Xu H, et al
Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma.
Oral Oncol. 2021;118:105313.
PubMed Abstract available

SINHA NK, Kohli PS, Nagarajan K, Gochhait D, et al
A nomogram for predicting the risk of neck node metastasis in oral cavity carcinoma using acoustic radiation force impulse imaging (ARFI).
Oral Oncol. 2021;118:105311.
PubMed Abstract available

YVER CM, Shimunov D, Weinstein GS, Rajasekaran K, et al
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
Oral Oncol. 2021;118:105307.
PubMed Abstract available

LYNCH PT, Horani S, Lee R, Sumer BD, et al
Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: A systematic review.
Oral Oncol. 2021;117:105253.
PubMed Abstract available

VALLINA C, Lopez-Pintor RM, Gonzalez-Serrano J, de Vicente JC, et al
Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review.
Oral Oncol. 2021;117:105310.
PubMed Abstract available

RAJASEKARAN K, Carey RM, Lin X, Seckar TD, et al
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis.
Oral Oncol. 2021;117:105305.
PubMed Abstract available

KREINBRINK PJ, Li J, Parajuli S, Wise-Draper TM, et al
Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Oral Oncol. 2021;116:105245.
PubMed Abstract available

DHAKAL R, Moeller BJ, Prabhu RS, Frenkel CH, et al
Pattern of distant metastasis in oropharyngeal carcinoma - Do they differ by HPV status?
Oral Oncol. 2021 Apr 18:105286. doi: 10.1016/j.oraloncology.2021.105286.
PubMed

FANNY C, Sebastien L, Pascale G, Antoine N, et al
Physician practice variation in head and neck cancer therapy: Results of a national survey.
Oral Oncol. 2021;117:105293.
PubMed Abstract available

MOUTAFI M, Economopoulou P, Rimm D, Psyrri A, et al
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data.
Oral Oncol. 2021;117:105292.
PubMed Abstract available

XIANG ZF, Hu DF, Xiong HC, Li MY, et al
Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database.
Oral Oncol. 2021;117:105284.
PubMed Abstract available

KUMAR R, Dheeraj K
Do ipsilateral lateralized squamous cell carcinomas of oral tongue with a depth of invasion (DOI) greater than 10 mm warrant a bilateral neck dissection to prevent future regional recurrences on contralateral side? A continuing conundrum.
Oral Oncol. 2021 Apr 7:105285. doi: 10.1016/j.oraloncology.2021.105285.
PubMed

SCHREIBER A, Mattavelli D, Accorona R, Rampinelli V, et al
Endoscopic-assisted multi-portal compartmental resection of the masticatory space in oral cancer: Anatomical study and preliminary clinical experience.
Oral Oncol. 2021;117:105269.
PubMed Abstract available

RAUSO R, Chirico F, Federico F, Francesco Nicoletti G, et al
Maxillo-facial reconstruction following cancer ablation during COVID-19 pandemic in southern Italy.
Oral Oncol. 2021;115:105114.
PubMed Abstract available

SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
Synchronous primary neoplasia in patients with p16 positive oropharyngeal carcinoma: Does the 2nd cancer really matters?
Oral Oncol. 2021;115:105113.
PubMed

PARAG-SHARMA K, Tasoulas J, Musicant AM, do Nascimento-Filho CHV, et al
Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
Oral Oncol. 2021;115:105166.
PubMed Abstract available

LIU HY, Tam L, Woody NM, Caudell J, et al
Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
Oral Oncol. 2021;115:105190.
PubMed Abstract available

LORINI L, Ardighieri L, Bozzola A, Romani C, et al
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
Oral Oncol. 2021;115:105213.
PubMed Abstract available

PRICE JM, West CM, Mistry HB, Betts G, et al
Improved survival prediction for oropharyngeal cancer beyond TNMv8.
Oral Oncol. 2021;115:105140.
PubMed Abstract available

TRETIAKOW D, Mollin E, Stodulski D
Metastasis of the testicular germ cell tumors to the parotid gland.
Oral Oncol. 2021;115:105132.
PubMed

LOMBARDI N, Varoni EM, Moneghini L, Lodi G, et al
Submucosal oral squamous cell carcinoma of the tongue.
Oral Oncol. 2021;115:105121.
PubMed

GANCI F, Allegretti M, Manciocco V, Fiorentino F, et al
Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood.
Oral Oncol. 2021;115:105096.
PubMed

HUANG NS, Cao YM, Lu ZW, Guan Q, et al
Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
Oral Oncol. 2021;115:105092.
PubMed Abstract available

March 2021

DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence" by Zotti F et al (May 2020).
Oral Oncol. 2021;114:105080.
PubMed

DE ALMEIDA JR, Seungyeon Kim V, O'Sullivan B, Goldstein DP, et al
Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.
Oral Oncol. 2021;114:105165.
PubMed Abstract available

FERRARI M, Migliorati S, Tomasoni M, Crisafulli V, et al
Sinonasal cancer encroaching the orbit: Ablation or preservation?
Oral Oncol. 2021;114:105185.
PubMed Abstract available

YANG K, Ahn YC, Nam H, Hong SD, et al
Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients.
Oral Oncol. 2021;114:105180.
PubMed Abstract available

HENG Y, Zhang D, Zhou L, Zhang M, et al
Assessment and treatment strategies for occult contralateral lymph node metastasis in hypopharyngeal squamous cell carcinoma patients with ipsilateral node-positive necks.
Oral Oncol. 2021;114:105183.
PubMed Abstract available

BENOIT C, Orbach D, Cyrille S, Belhous K, et al
Head and neck tumors in children and adolescents: Impact of a multidisciplinary tumor board.
Oral Oncol. 2021;114:105145.
PubMed Abstract available

CUI J, Wang D, Nie D, Liu W, et al
Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
Oral Oncol. 2021;114:105142.
PubMed Abstract available

OPPELT P, Ley JC, Worden F, Palka K, et al
Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial.
Oral Oncol. 2021;114:105164.
PubMed Abstract available

LIN NC, Su IH, Hsu JT, Chang YJ, et al
Comparison of different lymph node staging systems in patients with positive lymph nodes in oral squamous cell carcinoma.
Oral Oncol. 2021;114:105146.
PubMed Abstract available

LEE NCJ, Eskander A, Miccio JA, Park HS, et al
Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system.
Oral Oncol. 2021;114:105137.
PubMed Abstract available

GOOSMANN M, Chang S, Craig J
Treating sinonasal crusting and infection after palatal and sinonasal cancer resection with topical antibiotic irrigations.
Oral Oncol. 2021;114:105077.
PubMed

ERKUL E, Yilmaz I
TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
Oral Oncol. 2021;114:105089.
PubMed Abstract available

GOMES N, Huynh A, Borel C, Guenounou S, et al
Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort.
Oral Oncol. 2021;114:105082.
PubMed Abstract available

LEITE AK, Kulcsar MAV, Matsuura D, Matos LL, et al
Amelanotic melanoma presenting as a tongue tumor.
Oral Oncol. 2021;114:105075.
PubMed

SINGHAVI HR, Khare N, Singh A, Khandelwal A, et al
Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma.
Oral Oncol. 2021;114:105078.
PubMed Abstract available

DHARA V, Kudva A, Chithra A, Rajan J, et al
Reconstruction of buccal mucosa: A minimalist symbiotic approach with local flaps.
Oral Oncol. 2021;114:105081.
PubMed Abstract available

February 2021

FREIHAT O, Toth Z, Pinter T, Kedves A, et al
Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC).
Oral Oncol. 2021;116:105239.
PubMed Abstract available

FADEN DL, O'Boyle CJ, Lin DT, Deschler DG, et al
Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas.
Oral Oncol. 2021 Feb 15:105212. doi: 10.1016/j.oraloncology.2021.105212.
PubMed

SENGUPTA N, Sarode GS, Sarode SC, Gadbail AR, et al
Optimum surgical margins in squamous cell carcinoma of the oral tongue: Does shrinkage matters?
Oral Oncol. 2021;113:105052.
PubMed

GONZALEZ-MOLES MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, et al
Clinical interpretation of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP): Author's re
Oral Oncol. 2021;113:105036.
PubMed

TRETIAKOW D, Stodulski D, Mikaszewski B
Regarding the "Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures".
Oral Oncol. 2021;113:105026.
PubMed

LEE SJ, Kim YS, Kay CS, Kim M, et al
The effect of adjuvant chemotherapy and early tumor regression on the outcome of nasopharyngeal cancer patients treated with concurrent chemoradiotherapy.
Oral Oncol. 2021;113:105130.
PubMed Abstract available

MATSUYAMA R, Maeda K, Yamanaka Y, Ishida Y, et al
Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
Oral Oncol. 2021;113:105126.
PubMed Abstract available

CARNEVALE C, Ortiz-Gonzalez I, Ortiz-Gonzalez A, Bodi-Blanes L, et al
Early T1-T2 stage p16+ oropharyngeal tumours. Role of upfront transoral robotic surgery in de-escalation treatment strategies. A review of the current literature.
Oral Oncol. 2021;113:105111.
PubMed Abstract available

ROY P, Mallick I, Arun I, Zameer L, et al
Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
Oral Oncol. 2021;113:105115.
PubMed Abstract available

ADDERLEY H, Rack S, Hapuarachi B, Feeney L, et al
The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma.
Oral Oncol. 2021;113:105095.
PubMed Abstract available

KERAWALA CJ, Riva F, Paleri V
The impact of early oral feeding following head and neck free flap reconstruction on complications and length of stay.
Oral Oncol. 2021;113:105094.
PubMed Abstract available

SAKTHIVEL P, Panda S, Singh CA, Rajeshwari M, et al
T4a in 8th AJCC tongue cancers - A non-existent entity in surgical practice!
Oral Oncol. 2021;113:105051.
PubMed

HEFT NEAL ME, Gao RW, Brennan JR, Haring CT, et al
Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery.
Oral Oncol. 2021;113:105034.
PubMed

TERENZI V, Battisti A, Della Monaca M, Priore P, et al
Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria.
Oral Oncol. 2021;113:105032.
PubMed

January 2021

PILAR A, Yu E, Su J, O'Sullivan B, et al
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.
Oral Oncol. 2021;114:105167.
PubMed Abstract available

YILMAZ E, Ozbun MA, Gan GN
Molecular and immune signature of HPV-positive oral cavity squamous cell carcinoma.
Oral Oncol. 2021 Jan 25:105175. doi: 10.1016/j.oraloncology.2020.105175.
PubMed

BHATTASALI O, Torres FA, Kang HK, Thompson LDR, et al
Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimization.
Oral Oncol. 2021;114:105147.
PubMed

BURTNESS B, Ge J
Reply to "Keynote 48: Is it really for everyone?"
Oral Oncol. 2021;112:104983.
PubMed

YOUSSEF MR, Reisner ASC, Attia AS, Hussein MH, et al
Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer - Pooled results of 24 million cohorts.
Oral Oncol. 2021;112:105085.
PubMed Abstract available

SHER DJ, Yan J, Day AT, Khan S, et al
Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysis.
Oral Oncol. 2021;112:105029.
PubMed Abstract available

WANG D, Lu Y, Nannapaneni S, Griffith CC, et al
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
Oral Oncol. 2021;112:105074.
PubMed Abstract available

LOMBARDI D, Tomasoni M, Paderno A, Mattavelli D, et al
The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification.
Oral Oncol. 2021;112:105076.
PubMed Abstract available

WINDON MJ, Le D, D'Souza G, Bigelow E, et al
Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.
Oral Oncol. 2021;112:105044.
PubMed Abstract available

ALVES A, Diel L, Ramos G, Pinto A, et al
Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
Oral Oncol. 2021;112:105038.
PubMed Abstract available

BARROS DE OLIVEIRA A, Morandin Ferrisse T, Albergoni Silveira H, Vilela Silva E, et al
Intraoral atypical lentiginous melanocytic lesion in a pediatric patient.
Oral Oncol. 2021;112:105017.
PubMed Abstract available

NOGAL P, Bartkowiak E, Iwanik K, Wierzbicka M, et al
Common sense and tumor treatment. A case of pilomatrical carcinoma in a 21-year-old patient with surprisingly rapid tumor progression.
Oral Oncol. 2021;112:105007.
PubMed Abstract available

FLUKES S, Lohia S, Barker CA, Cracchiolo JR, et al
Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma.
Oral Oncol. 2021;112:105006.
PubMed

BHORIWAL S, Sharma J, Dhall K, Mandal A, et al
Duplication of the internal jugular vein - A rare anatomical variation.
Oral Oncol. 2021;112:104985.
PubMed

MANTSOPOULOS K, Iro H
Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures.
Oral Oncol. 2021;112:104986.
PubMed Abstract available

December 2020

CHRISTOPHERSON KM, Moreno AC, Elgohari B, Gross N, et al
Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
Oral Oncol. 2020;113:105125.
PubMed Abstract available

October 2020

FLEMING CW, Ward MC, Woody NM, Joshi NP, et al
Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
Oral Oncol. 2020;112:105046.
PubMed Abstract available

MILLIET F, Bozec A, Schiappa R, Viotti J, et al
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
Oral Oncol. 2020;112:105041.
PubMed Abstract available

CONTRERA KJ, Smile TD, Mahomva C, Wei W, et al
Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
Oral Oncol. 2020;111:105030.
PubMed Abstract available

August 2020

FAKHRY C, Fung N, Tewari SR, D'Souza G, et al
Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections.
Oral Oncol. 2020 Aug 29:104981. doi: 10.1016/j.oraloncology.2020.104981.
PubMed

July 2020

HSU AC, Kokot NC, Eisenberg BL, Thomas JS, et al
Complete response with talimogene laherparepvec in recurrent melanoma of the ear: A case report.
Oral Oncol. 2020 Jul 11:104899. doi: 10.1016/j.oraloncology.2020.104899.
PubMed Abstract available

June 2020

KREIMER AR, Chaturvedi AK, Alemany L, Anantharaman D, et al
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI.
Oral Oncol. 2020;108:104736.
PubMed Abstract available

May 2020

JOO YH, Cho KJ, Kim GJ, Kim MS, et al
Prognostic impact of resection margin involvement in surgically managed HPV-positive tonsil cancer.
Oral Oncol. 2020;108:104806.
PubMed Abstract available

KYLMA AK, Jouhi L, Mohamed H, Randen-Brady R, et al
In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.
Oral Oncol. 2020;107:104778.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.